Non-invasive Peripheral Perfusion Monitoring using Photoplethysmography
Musabbir Khan
A thesis submitted for the degree of Doctor of Philosophy in Bioengineering at the
University of Canterbury, Christchurch, New Zealand
September 2016

2

Acknowledgements
It is my great pleasure to thank a number of people and organization who have made my time working on this research during the last few years a rewarding experience.
My supervisors, Distinguished Prof. Geoff Chase, Dr Chris Pretty, and Dr Geoff Shaw, thank you for all of your support, patience, guidance and wisdom over the past few years. I have learnt a lot from you both and I appreciate the time you have given me.
Alexander, Joel, and Lachlan, thanks a lot for their technical support and assistance to make the MOOSE study happen and beyond. Thank you all for providing your contributions and sharing your knowledge.
St George’s Hospital, thanks for sponsoring the MOOSE study. In particular, thanks to Nikki Wood and all the staffs in the hospital ICU for their help, time, and support.
Rodney Elliott for providing his technical expertise and being patient at times. Thank you very much for your guidance and troubleshooting problems with my research equipment time to time.
All the colleagues in the Centre for Bioengineering, thanks for creating an amazing and friendly environment to work in, and organizing delicious potlucks. You all made life at work really nice. In particular, thanks to Guo, Azlan, Salwa, Alex, Shun, Hina, and Melanie for their friendship.
3

My parents, siblings, and my wife Ludmila, thank you all for your unconditional love, comfort, and encouragement throughout the duration of my studies. I could not have completed this work without the support you all have provided me outside of university. Finally, thanks to almighty god, Allah, for everything I am and everything I achieved. Please, always guide me in the right path.
4

Contents
Acknowledgements ............................................................................................ 3 Contents .............................................................................................................. 5 List of Figures...................................................................................................12 List of Tables .................................................................................................... 16 Nomenclature ...................................................... Error! Bookmark not defined. Abstract ............................................................................................................. 19 Chapter 1: Introduction .................................................................................. 23
1.1 Research overview.................................................................................34 1.1.1 Clinical significance of this research ........................................... 34 1.1.2 Research goals .............................................................................. 35
1.2 Preface....................................................................................................37 Chapter 2: Background and literature review ............................................. 40
2.1 Pulse oximetry and photoplethysmography..........................................40 2.1.1 History of pulse oximetry ............................................................ 41 2.1.2 Photoplethysmography origin......................................................42 2.1.3 Pulse oximetry principles.............................................................43 2.1.4 Beer-Lambert model .................................................................... 45 2.1.5 Empirical calibration to determine oxygen saturation ................ 46 2.1.6 Calibration free methods of SpO2 estimation .............................. 49
2.2 Photoplethysmography signal and modes ............................................ 50 2.2.1 PPG signal components ............................................................... 50 2.2.2 PPG waveform and shape ............................................................ 51 2.2.3 Transmission and Reflectance mode photoplethysmography .... 53
2.3 Applications of PPG and its limitations................................................54 2.3.1 Blood flow and perfusion monitoring ......................................... 54 2.3.2 Heart rate variability.....................................................................55 2.3.3 Cardiac output and pulse transit time .......................................... 55
5

2.3.4 Blood Pressure estimation............................................................56 2.3.5 Peripheral and systemic resistance assessment ........................... 57 2.3.6 Aging and vascular disease assessment.......................................57 2.3.7 Vasopastic conditions assessment ............................................... 58 2.3.8 Limitations....................................................................................58 2.4 Perfusion monitoring ............................................................................. 25 2.4.1 Definition......................................................................................25 2.4.2 Peripheral perfusion monitoring .................................................. 25 2.5 Perfusion and sepsis .............................................................................. 26 2.5.1 Epidemiology of sepsis ................................................................ 27 2.5.2 Microvascular perfusion dysfunction in sepsis ........................... 30 2.5.3 Assessment of peripheral perfusion during sepsis ...................... 32 2.5.4 Peripheral blood flow and SvO2 evaluation in sepsis ................. 33 2.6 Venous physiology and SvO2 assessment ............................................ 59 2.6.1 Physiology of peripheral venous compartment ........................... 60 2.6.2 Methods to assess tissue perfusion and SvO2..............................61 2.7 Existing research into non-invasive methods to assess SvO2 .............. 63 2.7.1 Venous pulsation using mechanical ventilation to assess SvO2 . 63 2.7.2 Estimation of SvO2 using natural venous pulsation .................... 64 2.7.3 External venous pulsation to assess SvO2 ................................... 65 2.7.4 Venous occlusion dependent peripheral SvO2 estimation using NIRS 66 2.7.5 Peripheral SvO2 estimation using NIRS ...................................... 68 2.8 Discussion and integration .................................................................... 69 2.9 Summary................................................................................................71 Chapter 3: Design and development of a novel pulse oximeter system .... 72 3.1 Introduction............................................................................................72 3.2 System Background...............................................................................73 3.3 Signal Acquisition ................................................................................. 74 3.3.1 Sensor principles .......................................................................... 74 3.3.2 Intensity control............................................................................75 3.3.3 Signal conditioning ...................................................................... 78
6

3.3.4 Signal sampling and recording .................................................... 80 3.4 Firmware and user interface development............................................81
3.4.1 Firmware and Finite state machine development........................81 3.4.2 Pulse oximeter user interface ....................................................... 83 3.5 Summary................................................................................................87 Chapter 4: PPG processing and analysis ...................................................... 88 4.1 Introduction............................................................................................88 4.2 Data and signal processing .................................................................... 89 4.2.1 Processing interface......................................................................89 4.2.2 Filter design and implementation ................................................ 89 4.3 Peak-trough detection ............................................................................ 92 4.3.1 Zero-crossing method...................................................................93 4.3.2 Trough-thresholding method ....................................................... 94 4.3.3 Crossing-crossing method............................................................95 4.3.4 Comparison tests between the three methods..............................96 4.4 SpO2 assessment .................................................................................... 99 4.4.1 R value estimation ........................................................................ 99 4.4.2 SpO2 estimation .......................................................................... 100 4.5 HR assessment ..................................................................................... 102 4.5.1 Frequency domain method.........................................................103 4.5.2 Time domain method .................................................................103 4.5.3 Comparison between the two methods......................................104 4.6 Summary..............................................................................................105 Chapter 5: Effect of temperature on PPG signal quality ......................... 106 5.1 Introduction..........................................................................................106 5.2 Related studies, test equipment and ethics..........................................107 5.2.1 Related study ..............................................................................107 5.2.2 Equipment set up for Study 1.....................................................108 5.2.3 Ethics approval for Studies 1 and 2 ...........................................109 5.3 Experimental Protocol.........................................................................109 5.3.1 Study 1........................................................................................109
7

5.3.2 Study 2........................................................................................111 5.4 PPG signal analysis .............................................................................112
5.4.1 Signals of interest .......................................................................112 5.4.2 Metric for SNR...........................................................................112 5.4.3 Statistical analysis ......................................................................113 5.5 Results .................................................................................................. 113 5.5.1 RMS data comparison ................................................................ 113 5.5.2 Tri-linear model..........................................................................114 5.5.3 Amplitude data comparison .......................................................116 5.5.4 Statistical differences .................................................................117 5.5.5 Correlation between pulse oximeters.........................................118 5.5.6 Main outcome from Study 2 ...................................................... 119 5.6 Discussion ............................................................................................ 120 5.6.1 Overall outcome .........................................................................120 5.6.2 Inaccuracy of the commercial pulse oximeter...........................124 5.6.3 Study limitation and validation..................................................125 5.7 Summary..............................................................................................125 Chapter 6: Monitoring peripheral blood flow changes using photoplethysmography 127 6.1 Introduction..........................................................................................127 6.2 Vascular Doppler Ultrasound..............................................................129 6.2.1 Technology Fundamentals ......................................................... 129 6.2.2 Doppler Velocity Waveform......................................................130 6.2.3 Other features and modification ................................................132 6.2.4 Preliminary tests .........................................................................133 6.3 Main Study...........................................................................................134 6.3.1 Ethics Approval..........................................................................134 6.3.2 Experimental Protocol................................................................134 6.3.3 Signal Analysis...........................................................................136 6.4 Results .................................................................................................. 137 6.4.1 Blood flow change detection ..................................................... 137 6.4.2 Median PPG and Doppler data analysis ...................................139
8

6.4.3 Correlation between the two measurements..............................142 6.4.4 Heart rate assessment .................................................................143 6.5 Discussion ............................................................................................ 144 6.5.1 Blood flow trends .......................................................................144 6.5.2 Vasodilation during post occlusion hyperemia .........................146 6.5.3 Overall outcome .........................................................................147 6.5.4 Study Limitations .......................................................................148 6.6 Summary..............................................................................................149 Chapter 7: Estimation of peripheral venous saturation and oxygen extraction using a novel pulse oximeter method ..................................................................................150 7.1 Introduction..........................................................................................150 7.2. Artificial venous blood modulation using the compliance difference principle 151 7.2.1 Arterial-venous compartment compliance difference principle151 7.2.2 Artificial pulse generation system development .......................153 7.2.3 APG pressure control and selection test ....................................154 7.2.4 APG frequency selection test.....................................................155 7.2.5 GUI to operate APG...................................................................156 7.3 Study protocol and data processing ....................................................157 7.3.1 Ethics approval ...........................................................................157 7.3.2 Study protocol ............................................................................157 7.3.3 Data processing and analysis .....................................................158 7.4 Results and discussion.........................................................................160 7.4.1 Venous pulse detection .............................................................. 160 7.4.2 Instantaneous saturation estimation ...........................................162 7.4.3 SpO2 assessment by the two pulse oximeters............................163 7.4.4 Main Outcome............................................................................163 7.4.5 Limitations and future work.......................................................165 7.5 Summary..............................................................................................166 Chapter 8: Clinical validation trial of a novel pulse oximeter concept for non-invasive estimation of peripheral venous saturation ................................................167 8.1 Introduction..........................................................................................167
9

8.1.1 MOOSE trial Background..........................................................168 8.2 Improvements to the APG system and PPG processing ....................168
8.2.1 Pressure regulation with ITV001...............................................169 8.2.2 Pressure regulation interface ...................................................... 170 8.2.3 Additional filter to extract APG signals ....................................171 8.3 Ethics approval and study cohort ........................................................172 8.3.1 HDEC ethics approval ............................................................... 172 8.3.2 Study cohort................................................................................172 8.4 Methodology, trial protocol and modifications ..................................173 8.4.1Additional equipment employed.................................................173 8.4.2 Study set up procedure ...............................................................174 8.4.3 Experimental protocol ................................................................ 175 8.4.4 Problems encountered and changes in study procedure............179 8.5 Data processing and Analysis .............................................................181 8.5.1 Data processing ..........................................................................181 8.5.2 Statistical analysis ......................................................................182 8.5.3 Error propagation analysis .........................................................182 8.6 Results .................................................................................................. 186 8.6.1 Detection of AC and APG signals from PPG............................ 186 8.6.2 Interesting findings in Test 4 ..................................................... 188 8.6.3 Correlation between RVen and SvO2 .......................................... 190 8.6.4 Study Measurements ..................................................................192 8.7 Discussion ............................................................................................ 195 8.7.1 Main outcome.............................................................................195 8.7.2 Difference between RArt and RVen modulation ratios ................196 8.7.3 Low oxygen saturation detection using PPG ............................197 8.7.4 Limitations..................................................................................200 8.8 Summary..............................................................................................201 Chapter 9: Conclusions .................................................................................203 9.1 Outcomes from Thesis: Part 1 ............................................................. 203 9.2 Outcomes from Thesis: Part 2 ............................................................. 205
10

9.3 Overall outcome ..................................................................................207 Chapter 10: Future Work.............................................................................209
10.1 Improvements to the PO system .......................................................209 10.2 Modifications to the sensor and clinical applicability......................210 10.3 Assessment of absolute blood flow...................................................211 10.4 Further testing and application of the SvO2 estimation model ........ 211 References .......................................................................................................213 Appendix ......................................................................................................... 230
11

List of Figures
FIGURE 1.1: CRITERIA FOR SIRS, SEPSIS, SEVERE SEPSIS, AND SEPTIC SHOCK ACCORDING TO THE 1991 ACCP/SCCM CONSENSUS CONFERENCE. ADAPTED FROM: BONE ET AL. (1992). ...........27
FIGURE 1.2: SEPSIS HAVING THE HIGHEST NUMBER OF INCIDENCES IN US/EUROPE RECEIVING THE LOWEST AMOUNT RESEARCH FUNDING COMPARED TO OTHER MEDICAL CONDITIONS. SOURCE: KUNZ (2012)................................................................................................................................29
FIGURE 1.3: RELATIONSHIP BETWEEN SUBLINGUAL MICROCIRCULATION AND ICU MORTALITY IN 252 PATIENTS WITH SEVERE SEPSIS. THE PATIENTS WERE GROUPED INTO QUARTILES IN PROPORTION OF PERFUSED CAPILLARIES. SOURCE: DE BACKER ET AL. (2014). ..............................................31
FIGURE 2.1: ABSORPTION SPECTRA OF THE FOUR TYPES OF HAEMOGLOBIN, SHOWING THE EXTINCTION COEFFICIENTS (LMMOL-1CM-1) AT RED AND INFRARED WAVELENGTHS. REPRODUCED FROM TREMPER AND BARKER (1989)...................................................................44
FIGURE 2.2: TYPICAL PULSE OXIMETER CALIBRATION CURVE ALSO SHOWING THE BEER-LAMBERT MODEL. SOURCE: ROSS (1999). ..................................................................................................47
FIGURE 2.3: DYNAMIC LIGHT ABSORPTION OF VASCULAR BED DURING CARDIAC CYCLE. SOURCE: TAMURA ET AL. (2014). ...............................................................................................................51
FIGURE 2.4: A TYPICAL PPG WAVEFORM PULSE SHOWING SOME FEATURES. .....................................52 FIGURE 2.5: TRANSMISSION VS REFLECTION MODE PHOTOPLETHYSMOGRAPHY ................................53 FIGURE 3.1: HARDWARE CIRCUITRY OF PO SYSTEM, ALONG WITH THE SENSOR.................................73 FIGURE 3.2: BLOCK DIAGRAM FOR THE PO SYSTEM............................................................................74 FIGURE 3.3: SENSOR LED TIMING DIAGRAM .......................................................................................75 FIGURE 3.4: LED SWITCHING AND INTENSITY CONTROL CIRCUIT DIAGRAM, WHERE TRANSISTORS Q1
AND Q4 ARE THE CONTROLLING THE IR LED, AND Q2 AND Q3 ARE CONTROLLING THE RD LED. ............................................................................................................................................76 FIGURE 3.5: RELATIONSHIP BETWEEN LED CURRENT VS DAC COUNT, THUS LED INTENSITY CHARACTERISTICS. ....................................................................................................................... 77 FIGURE 3.6: RELATIONSHIP BETWEEN BEAM POWER AND DAC COUNT FOR RD AND IR LEDS.........78
12

FIGURE 3.7: TRANSIMPEDANCE AMPLIFIER CIRCUIT, WHERE U1 REPRESENTS STAGE1 AND U2 REPRESENTS STAGE 2 AMPLIFIERS, RESPECTIVELY......................................................................79
FIGURE 3.8: BLOCK DIAGRAM SHOWING THE LED CURRENT CONTROL, THE TRANSIMPEDANCE AMPLIFIER STAGES, AND THE ADC END OF THE PULSE OXIMETER’S FRONT-END. ......................80
FIGURE 3.9: PO SYSTEM FIRMWARE TOP LEVEL BLOCK DIAGRAM. .....................................................82 FIGURE 3.10: FSM STATES AND TRANSITIONS FOR LED INTENSITY CONTROL ...................................82 FIGURE 3.11: FLOWCHART FOR THE PPG ACQUISITION AND MONITORING GUI.................................85 FIGURE 3.12: PULSE OXIMETER LABVIEW GUI, SHOWING THE MONITORING TAB IN THE FRONT
PANEL ........................................................................................................................................... 86 FIGURE 4.1: FILTER DESIGN OF THE FIRST STAGE LOW PASS FILTER, WHICH REMOVES HIGH
FREQUENCY NOISE FROM THE PPG ..............................................................................................91 FIGURE 4.2: AN EXAMPLE OF PPG DATA WITH IDENTIFIED PEAKS AND TROUGHS. .............................93 FIGURE 4.3: THREE PEAK-TROUGH DETECTION METHODS WERE APPLIED FOR A GIVEN PPG SIGNAL;
ZERO-CROSSING (TOP), TROUGH-BASED THRESHOLDING (MIDDLE), CROSSING-CROSSING (BOTTOM). INCORRECT OR MISSED PEAKS/TROUGHS ARE HIGHLIGHTED WITH DASHED BLUE CIRCLE. ......................................................................................................................................... 97 FIGURE 4.4: AMPLITUDE |AC| AND CORRESPONDING DCMEAN VALUES DETERMINED FROM IR AC AND DC SIGNALS, RESPECTIVELY, AS AN EXAMPLE. ...........................................................................99 FIGURE 4.5: INSTANTANEOUS AND OVERALL SPO2 ESTIMATED FOR A TEST PPG DATA USING EQUATION 4.5.............................................................................................................................102 FIGURE 4.6: POWER SPECTRAL DENSITY OF THE IR PPG, WITH THE DC COMPONENT REMOVED, AS AN EXAMPLE. ALL THE CARDIAC FREQUENCIES ARE LABELLED. THE HIGHEST PEAK MAGNITUDE, AT ABOUT 1 HZ, IS THE HR. ............................................................................................................103 FIGURE 4.7: PPG BASED HR ASSESSMENT USING THE TWO METHODS; FFT BLOCK METHOD (TOP) AND PEAK-PEAK BLOCK METHOD (BOTTOM).....................................................................................104 FIGURE 5.1: FLOWCHART OF THE EXPERIMENTAL PROTOCOL, SHOWING THE STEP-BY-STEP PROCESS. THE OVERALL SERIES OF TEST CAPTURES NORMAL, RELATIVELY COLD AND RELATIVELY WARM TEMEPRATURES. ......................................................................................................................... 110 FIGURE 5.2: AC SIGNAL RMS VERSUS TEMPERATURE FROM THE THREE DIFFERENT EXPERIMENTS: IR (LEFT), RD (RIGHT). ...................................................................................................................115 FIGURE 5.3: MEDIAN AC SIGNAL AMPLITUDE FOR THE COHORT FROM THE THREE TESTS. ...............116
13

FIGURE 5.4: AC SIGNALS FROM THE 3 TESTS FOR SUBJECTS 19 (LEFT) AND 20 (RIGHT): COLD (A), BASELINE (B), AND WARM (C)...................................................................................................117
FIGURE 5.5: FRONT PANEL OF NPB-75 DISPLAYING PPG SIGNAL AND DATA FOR SUBJECT 20: COLD (LEFT), BASELINE (MIDDLE) AND WARM (RIGHT). ....................................................................118
FIGURE 6.1: TYPICAL APPEARANCE OF A DIRECTIONAL DOPPLER WAVEFORM FROM A NORMAL COMMON FEMORAL ARTERY (A), SHOWING THE FLOW ENVELOPE AT VARIOUS PHASES OF THE FLOW CYCLE (B) AND RELATED VELOCITIES. ADAPTED FROM (VOWDEN AND VOWDEN, 2004) ................................................................................................................................................... 131
FIGURE 6.2: MOUNTING DESIGNED TO ASSIST IN HOLDING THE BV-520T PROBE AT FIXED 30° ANGLE OF INSONATION ..........................................................................................................................132
FIGURE 6.3: THE BV-520T AND PO SENSORS SET UP DURING THE STUDY........................................135 FIGURE 6.4: PEAK-TROUGH DETECTION ALGORITHM, TO EXTRACT AC AMPLITUDE (|AC|)
INFORMATION FROM THE AC SIGNAL OF RD AND IR PPGS......................................................137 FIGURE 6.5: BLOOD FLOW CHANGE TREND CAPTURED FOR ONE SUBJECT DURING THE WHOLE
EXPERIMENT WITH PPG (TOP) AND DOPPLER (BOTTOM)...........................................................138 FIGURE 6.6: TRAJECTORY OF THE MEDIAN AC SIGNAL AMPLITUDE AND DOPPLER VELOCITY VALUES
FOR THE WHOLE STUDY; PHASE 1 – BASELINE, PHASE 2 – PARTIAL OCCLUSION, PHASE 3 – FULL OCCLUSION, PHASE 4 – RECOVERY1, PHASE 5 – RECOVERY 2. ................................................141 FIGURE 6.7: CORRELATION BETWEEN MEAN PULSE AMPLITUDE AND VELOCITY OF BLOOD FLOW FOR THE WHOLE COHORT ..................................................................................................................142 FIGURE 6.8: DETECTED HR TREND USING THE PPG SENSOR TREND FOR SUBJECT 2 DURING THE EXPERIMENT, WITH NO HR DETECTED DURING FULL OCCLUSION. ............................................143 FIGURE 7.1: CROSS SECTION VIEW OF A TYPICAL ARTERY AND VEIN, DEPICTING THE DIFFERENCE IN VESSEL ELASTICITY. ADAPTED FROM: WESTER ET AL. (2013). .................................................151 FIGURE 7.2: THE RELATIONSHIP BETWEEN VOLUME AND PRESSURE WITHIN BOTH THE ARTERIAL AND VENOUS SYSTEMS. ADAPTED FROM: (WARDHAN AND SHELLEY (2009); MOHRMAN ET AL. (2006); KLABUNDE (2011); WESTER ET AL. (2013); HALL (2006))..........................................152 FIGURE 7.3: PPG SENSOR AND DIGIT CUFF PLACEMENT ....................................................................153 FIGURE 7.4: APG SYSTEM FUNCTIONAL BLOCK DIAGRAM ILLUSTRATING OVERALL OPERATION.....155 FIGURE 7.5: LABVIEW GUI USED TO CONTROL THE APG SYSTEM .................................................156
14

FIGURE 7.6: DERIVED COMPONENTS FROM WALTON’S TIME DOMAIN EQUATIONS, IN TERMS OF THE AC AND DC PPG SIGNALS. .......................................................................................................159
FIGURE 7.7: PPG SIGNALS OF SUBJECT 6: DC (TOP), AC (MIDDLE) AND RAW (BOTTOM) FOR EACH SUBJECT. ....................................................................................................................................161
FIGURE 7.8: PPG SIGNALS OF SUBJECT 9: DC (TOP), AC (MIDDLE) AND RAW (BOTTOM) FOR EACH SUBJECT. ....................................................................................................................................161
FIGURE 7.9: INSTANTANEOUS SAO2 AND SVO2 CALCULATED FOR SUBJECTS 6 AND 9, FOR AN ILLUSTRATIVE PORTION OF THE BASELINE AND APG PERIODS..................................................162
FIGURE 7.10: POWER SPECTRUM OF IR PPG SIGNAL FOR SUBJECT 4, WITH LABELLED HARMONICS. ................................................................................................................................................... 165
FIGURE 8.1: BLOCK DIAGRAM OF THE ITV001 PRESSURE REGULATOR WORKING PRINCIPLE. ..........169 FIGURE 8.2: LABVIEW BASED APG PRESSURE CONTROL GUI. .......................................................171 FIGURE 8.3: TYPICAL EQUIPMENT SET UP FOR THE MOOSE STUDY. ALL COMPONENTS ARE
INDIVIDUALLY LABELLED. .........................................................................................................175 FIGURE 8.4: CLINICIANS DRAWING VENOUS BLOOD SAMPLE FROM THE PERIPHERAL VEIN OF A
SUBJECT VIA THE VENOUS LINE IV CATHETER...........................................................................177 FIGURE 8.5: A SUBJECT EXERCISING THE HAND USING A SQUASHABLE TOY DURING TEST 3............179 FIGURE 8.6: BASELINE PPG SIGNALS SHOWING PRE APG AND POST APG PHASES FOR SUBJECT 7;
STARTING FROM THE TOP 1) AC SIGNAL, 2) APG SIGNAL, 3) DC SIGNAL, AND 4) RAW SIGNAL. ................................................................................................................................................... 186 FIGURE 8.7: FREQUENCY POWER SPECTRUMS FOR SUBJECT 7 FROM TEST 1 WITH LABELLED FREQUENCIES; (A) AC SIGNAL AT RD, (B) AC SIGNAL AT IR, (C) APG SIGNAL AT RD, (D) APG SIGNAL AT IR, (E) DC SIGNAL AT RD, AND (F) DC SIGNAL AT IR.............................................188 FIGURE 8.8: PPG SIGNALS FOR SUBJECT 7 IN TEST 4; STARTING FROM THE TOP 1) AC SIGNAL, 2) APG SIGNAL, 3) DC SIGNAL, AND 4) RAW SIGNAL. ................................................................189 FIGURE 8.9: CORRELATION (R2 = 0.9515) BETWEEN ALL ESTIMATED RVEN AND MEASURED SVO2 SAMPLES ACROSS THE WHOLE COHORT FROM THE 3 TESTS. THE SOLID BLUE LINE IS THE PROPOSED SPVO2 CALIBRATION MODEL AND THE DASHED RED LINE IS THE EMPIRICAL SPO2 CALIBRATION MODEL (WEBSTER, 2002). ..................................................................................191
15

List of Tables
TABLE 1.1: WORLDWIDE INCIDENCES OF SEPSIS AND RELATED MORTALITY AS DETERMINED IN 8 STUDIES. ....................................................................................................................................... 28
TABLE 4.1: SPECIFICITY AND SENSITIVITY RATINGS FOR ASSESSED PEAK-TROUGH DETECTION ALGORITHMS ................................................................................................................................ 97
TABLE 5.1: DEMOGRAPHICS, PPG SIGNAL RMS, AND MEDIAN TEMPERATURE DATA FOR ALL SUBJECTS FROM THE STUDY .......................................................................................................114
TABLE 5.2: RESULTS OF NON-PARAMETRIC STATISTICAL TEST COMPARISON BETWEEN EXPERIMENTAL DATA SETS..................................................................................................................................117
TABLE 5.3: MEDIAN SPO2 DATA OF ALL SUBJECTS FROM THE EXPERIMENT ....................................119 TABLE 5.4: PPG SIGNAL RMS AND MEDIAN DIGIT SKIN TEMPERATURE VALUES FOR ALL SUBJECTS IN
STUDY 2. ....................................................................................................................................120 TABLE 6.1: PSV MEASUREMENTS FROM THE PRELIMINARY TEST, S1 MEANS SET 1 AND S2 MEANS SET
2. ................................................................................................................................................133 TABLE 6.2: MEDIAN [IQR] AC SIGNAL AMPLITUDE (V) AND DOPPLER ULTRASOUND VELOCITY
(CM/S) DATA FROM THE STUDY ..................................................................................................140 TABLE 7.1: SUBJECT DEMOGRAPHICS AND SAO2 ESTIMATION COMPARISON BY TWO PULSE
OXIMETERS ................................................................................................................................. 163 TABLE 7.2: SUBJECT ESTIMATED SATURATION VALUES FROM THE EXPERIMENT..............................164 TABLE 8.1: ESTIMATED RVEN, MEASURED SVO2, AND RELATED UNCERTAINTIES FOR EACH SUBJECT
FROM THE WHOLE STUDY...........................................................................................................190 TABLE 8.2: BASELINE PPG AND BLOOD GAS MEASUREMENTS FOR ALL THE SUBJECTS ....................192 TABLE 8.3: PPG AND BLOOD GAS MEASUREMENTS FOR ALL THE SUBJECTS FROM TEST 2 ...............193 TABLE 8.4: PPG AND BLOOD GAS MEASUREMENTS FOR ALL THE SUBJECTS FROM TEST 4 ...............194 TABLE 8.5: MEASURED AND ESTIMATED OXYGEN SATURATION DIFFERENCES FOR ALL SUBJECTS,
ACROSS THE THREE TESTS. NO MEASURED OR ESTIMATED ARTERIAL OXYGEN SATURATIONS FOR SOME SUBJECTS ARE PRESENTED AS EXPLAINED IN SECTION 8.4.4. ..........................................195
16

Nomenclature

AC ADC APG
BP BF BV CO COM CSA DAC DAQ DC DSP ECG EDV FFT FIR FSM GUI Hb HbO2 HCO3 HDEC HR HRV ICU IIR IR IV

High frequency component of the PPG signal Analog-to-digital converter Artificial pulse generation Blood pressure Blood flow Blood velocity Cardiac output Communication (port) Cross sectional area Digital-to-analog converter Data acquisition Low frequency component of the PPG signal Digital signal processor Electrocardiogram End diastolic velocity Fast Fourier Transform Finite impulse response Finite state machine Graphical user interface De-oxygenated haemoglobin Oxygenated haemoglobin Bicarbonate Health and Disability Ethics Committee Heart rate Heart rate variability Intensive care unit Infinite impulse response Infrared light/wavelength Intravenous

17

LED MCU MOOSE NIRS
O2E PCO2
PD pH PI PPG PO PO2 PSV PTT PTTR
R RArt RVen RBC RD RMS RPO SaO2 SpO2 SO2 SpaO2 SNR SvO2 SpvO2 StO2
T TPO VOT

Light emitting diode Microcontroller unit Monitoring Oxygen for Saturation and Extraction Near infrared spectroscopy Oxygen extraction Partial pressure of carbon dioxide Photo diode/Photodetector Acidity (of blood) Perfusion Index Photoplethysmograph Pulse oximeter Partial pressure of oxygen Peak systolic velocity Pulse transit time Pulse time reflection ratio Modulation ratio R value derived from AC and DC signals R value derived from APG and DC signals Red blood cell Red light/wavelength Root mean squares Reflectance mode PPG Arterial blood oxygen saturation Pulse oximeter estimated SaO2 Oxygen saturation Custom pulse oximeter estimated SaO2 Signal-to-noise ratio Venous blood oxygen saturation Custom pulse oximeter estimated SvO2 Tissue oxygen saturation Temperature Transmission mode PPG Vascular Occlusion Test

18

Abstract
In the intensive care unit (ICU), cardiovascular disease and sepsis are major drivers of morbidity, mortality, and cost. Microcirculatory dysfunction during sepsis and cardiac failure is known to significantly impair perfusion in major organs and peripheral tissues, resulting in poor patient outcome if not corrected early. Arterial oxygen saturation (SaO2), venous oxygen saturation (SvO2), and their difference, or oxygen extraction (O2E), in association with blood flow, are key parameters necessary to assess tissue perfusion. Although, SaO2 can be reliably estimated by noninvasive optical technologies, such as pulse oximetry in terms of SpO2, there are no established, easy, or non-invasive methods to assess SvO2, and thus O2E. Therefore, real-time, low-cost, and non-invasive assessment of SvO2, O2E, and blood flow could significantly advance the diagnosis, management, and of care sepsis or cardiovascular disease in the ICU.
This research focuses on the development of a novel pulse oximeter based concept to noninvasively and more completely assess tissue perfusion in peripheral extremities, such as the finger. A transmittance pulse oximeter sensor was used as the basis of a device to estimate and monitor peripheral SvO2, O2E, and blood flow changes. Robustness of perfusion assessment methods at various digit skin temperatures was also investigated to improve accuracy and define the limits of sensor accuracy.
A custom built pulse oximeter (PO) device and graphical user interface (GUI) were developed to access and acquire all photoplethysmograph (PPG) signals, including the raw PPG signals. A two
19

stage digital filter system was implemented to extract useful signals from the PPG. Time and frequency domain methods, including peak-trough detection algorithms, were developed to analyse the PPG data and estimate parameters, such as SaO2 and heart rate. This system was thus used as the basis for developing SvO2 and blood flow monitoring methods, and also the investigation of temperature effects on PPG measurements.
A study was conducted with healthy adult volunteers (n = 20) to investigate the effect of a range of digit skin temperatures on pulse oximeter performance using a transmittance pulse oximeter sensor. It was hypothesized that cold digits can significantly reduce PPG signal quality and the resulting accuracy of SpO2 measurements, due to the likely reduction in blood flow of the periphery at these temperatures. PPG data were recorded at cold, normal, and baseline skin temperatures, using the PO system as well as a commercial pulse oximeter for reference. Results show warm skin temperatures improved PPG signal quality up to 64.4% compared to baseline, and provided SpO2 estimation of 96.5[96.1 – 97] % in the expected range for healthy adults. At baseline conditions, the majority of subjects showed a good PPG signal and expected SpO2 estimate of 95.8[93.2 – 96.8] %. PPG signal quality degraded significantly up to 54.0% at cold conditions and SpO2 estimates of 88.5[87.1 – 92.8] % were unreliable when compared to baseline. The main outcome is a tri-linear model quantifying PPG signal quality as a function of temperature, suggesting warm skin temperature conditions (approximately 33°C) should be maintained for reliable transmittance pulse oximetry.
In circulatory dysfunction, peripheral blood flow can be reduced, adding error to assessment of SvO2 and O2E using typical models and assumptions. Relative volumetric blood flow change
20

assessments using the PO sensor were performed in a study using 7 human adult volunteers. The signal amplitude of the high frequency PPG component, which is related to the pulsatile arterial blood flow, was used as an indicator of blood flow change. A vascular Doppler ultrasound sensor was used as a reference measurement. Changes in blood flow conditions were induced by a series of vascular occlusion tests. Good correlation (R2 = 0.69) and trend agreement was obtained between median PPG amplitude and Doppler ultrasound velocity, particularly at normal and clinically important low flow conditions. Thus, PPG amplitude monitoring can be a potential surrogate or alternative to vascular Doppler ultrasound based blood velocity monitoring, and can provide continuous and reliable measurements, ensuring flow conditions can be included in assessing SvO2.
A novel artificial pulse generation system (APG) was developed to cause low frequency and low pressure modulations of venous blood in the finger using a pneumatic digit cuff. The APG system used a feedback controlled pressure regulator and solenoid valve to inflate/deflate the pressure cuff. This system was designed to exploit the significant arterial-venous compliance difference and make the peripheral venous blood pulsatile, while having negligible impact on arterial blood flow. Ten healthy human adults were recruited for proof-of-concept testing of this device. Modulation ratio (R) values derived from the artificially modulated PPG signals were used to estimate venous oxygen saturation (SpvO2) using an empirical calibration equation developed for arterial blood. Conventional empirical calibration model estimated arterial and venous saturations of 96.95[96.1 – 97.4] % and 93.15[91.1 – 93.9] % agree with published literature values. Median O2E was 3.6%, with a statistically significant and expected difference (p = 0.002) between pairs of measurements in each subject.
21

The APG system in association with the pulse oximeter device to assess SvO2 was then validated in a clinical study with healthy adult volunteers (n = 8). A range of physiologically realistic SvO2 values were induced using vascular occlusion tests. Gold standard, arterial and venous blood gas measurements were used as reference measurements. Modulation ratios related to arterial and venous systems were determined using a frequency domain analysis of the PPG signals. A strong, linear correlation (R2 = 0.95) was found between estimated venous modulation ratio and measured SvO2, providing a calibration curve relating measured modulation ratio of venous blood to oxygen saturation. Median venous and arterial oxygen saturation accuracies from paired measurements were 0.29% and 0.65%, respectively, showing good accuracy of the pulse oximeter system. Investigations also revealed the empirical calibration model used to estimate SpaO2 cannot be used estimate SpvO2 because of the difference in optical absorption caused by artificial perturbations. In particular, there is a significant difference in gradient between the SpvO2 estimation model (SpvO2 = 111 – 40.5*R) and the empirical SpaO2 estimation model of (SpaO2 = 110 – 25*R). The main outcome of this study presents a novel pulse oximeter based calibration model that can be used to assess peripheral SvO2, and thus O2E, using the device developed in this work.
Overall, this thesis successfully develops and demonstrates a non-invasive, pulse oximeter based method to assess peripheral tissue perfusion in terms of SaO2, SvO2, O2E and volumetric blood flow changes. This novel sensor may potentially detect peripheral perfusion alterations in real-time during microvascular and/or overall circulatory dysfunction, such as in sepsis or cardiac failure. Future work will follow the application of the novel sensor in a comprehensive clinical study with a larger, more diverse, cohort.
22

Chapter 1: Introduction
Healthcare economics are getting increasingly difficult. Costs are increasing rapidly, driven largely by rising demands due to aging populations and chronic diseases (Dorman and Pauldine, 2007; Bloomfield, 2003). These trends are unsustainable, eroding the quality, access, and equity of healthcare for all. In addition, the future of healthcare is broadly regarded as personalised, predictive, preventive and participatory (Hood and Friend, 2011), as well the demand to be more productive, and thus more economically affordable. In particular, better quality, more productive, and cost effective care are the primary demands and expectations of future healthcare.
The intensive care unit (ICU) is a leading source of hospital admission, mortality and cost. In the ICU, cardiovascular and circulatory failure and management are major drivers of morbidity, mortality, and cost. Alterations in oxygen transport and use can influence development of septic shock (Trzeciak et al., 2007), cardiovascular diseases (Rostand et al., 1984), and multiple organ failure (Moore et al., 1992). Prospective trials have reported positive outcomes when early treatment is directed towards restoration of adequate tissue perfusion (Vincent et al., 2003). Thus, the primary objective of circulatory resuscitation and management is to re-establish effective tissue perfusion and oxygenation, and thus cellular metabolism.
The main clinical endpoints or goals in monitoring circulatory functions and its response to care during circulatory management and resuscitation include, but are not limited to:
23

 The heart’s ability as a pump in terms cardiac output or accurate beat to beat stroke volume (SV) measurements (Uzzan et al., 2006), where recent surveys and consensus statements indicate that SV might be more preferred (Cecconi et al., 2014).
 The heart and circulatory systems ability to perfuse organs via determination of stressed blood volume using a model-based metric (Matson et al., 1991).
 The circulatory systems ability to exchange oxygen with tissues as a measure of arterial oxygen saturation (SaO2), which is commonly done non-invasively (Jubran, 2015), venous oxygen saturation (SvO2), which is commonly done invasively, (Chan and Gu, 2011), and the difference between the two saturations or oxygen extraction (O2E).
However, treatment end points remain significantly controversial because of the difficulties in determining what is constituted to be “optimal” in terms of these values. Information obtained from global, whole-body monitoring may not identify regional organ blood flow and oxygenation, or perfusion, abnormalities until they are severe. Equally, the ideal “canary” organ that is easily accessible for monitoring tissue perfusion, and thus can work as an early and sensitive marker of tissue abnormalities, remains to be established. Hence, there is a need for better measurements, preferably that are not invasive or make use of existing standard measurements.
Perfusion monitoring can be the key to promptly diagnose and manage possible organ dysfunction or tissue abnormalities. This monitoring is considered integral to determine postoperative outcomes after cardiac surgery (Kuttila and NiinikoskiI, 1989). In particular, peripheral perfusion monitoring can be used to determine abnormalities in tissue microcirculation, independent of systemic haemodynamics parameters (Ait-Oufella et al., 2011; van Genderen et al., 2014; van Genderen et al., 2012a), and is considered for investigation in this thesis.
24

1.1 Perfusion monitoring 1.1.1 Definition The word perfusion is derived from the French verb "perfuser", which means to "pour over or through" (Keane and Toole, 2003). In physiology, perfusion is the process by which blood is delivered to a capillary bed, in biological tissue, for tissue oxygenation and cellular metabolism. The concept of tissue perfusion has been linked to blood flow and oxygen delivery, or a combination of flow and nutritional supply, including oxygen. Overall, the transportation of oxygen to tissues and its absorption by the cells could be defined as tissue oxygen perfusion (Gottrup, 1994). Thus, the assessment of tissue blood flow and oxygen consumption lies at the core of tissue oxygen perfusion monitoring.
1.1.2 Peripheral perfusion monitoring Peripheral tissues are sensitive to alterations in perfusion. Hypoperfusion in peripheral tissues is associated with the severity of organ dysfunction and outcome, and is independent of systemic haemodynamics (Lima et al., 2009; Lima et al., 2011; Cohn et al., 2007). In addition, prolonged peripheral capillary refill time was strongly correlated with reduced perfusion assessed by increased proven tissue infection in previous studies (Bohnhorst et al., 2012; Van den Bruel et al., 2010). Thus, the assessment of peripheral perfusion can be used as an early indicator of systemic haemodynamic disorder (van Genderen et al., 2012b).
In various patient categories, more severe and persistent alterations in peripheral perfusion have been associated with poor outcomes, and these correlations were independent of systemic haemodynamic parameters (Ait-Oufella et al., 2011; van Genderen et al., 2014; van Genderen et
25

al., 2012a). In addition, interventions directed at systemic parameters can have an unpredictable effect on peripheral circulation parameters, especially during hyperdynamic conditions (Bonanno, 2011; Lima and Bakker, 2015). Thus, it appears that changes in peripheral perfusion can reflect changes in regional vasomotor tone, rather than systemic perfusion, which requires invasive procedures for perfusion monitoring with typical available methods.
Peripheral circulation deterioration has frequently been observed in critically ill patients using subjective assessment and optical techniques. In a prospective study of 108 healthy volunteers and 37 critically ill patients, peripheral perfusion was assessed and compared between the two groups using a peripheral perfusion index (PFI) based on the analysis of non-invasive pulse oximetry (Lima et al., 2002). The variation of the PFI in both groups was related to the central-to-toe temperature difference and capillary refill time after changes were detected in clinical signs of peripheral perfusion. It was concluded that changes in PFI strongly correlated to changes in coreto-toe temperature difference in critically ill patients, but not in healthy subjects (r2 = 0.52, p <0.001). However, although their research measured oxygen supply, no measurement for blood flow or oxygen consumption was provided, which would have strengthened the result.
1.2 Perfusion and sepsis Sepsis is a major public health risk associated with high morbidity and mortality. It is a complex medical condition characterised by a system inflammatory response syndrome (SIRS) in association with presumed or proven infection. In 1991, the American College of Chest Physicians and Society of Critical Care Medicine Consensus developed a framework to define SIRS, sepsis and severe sepsis (Bone et al., 1992), outlined in Figure 1.1. The criteria were later revised to
26

include infection and the presence of any diagnostic criteria, based on clinical or laboratory parameters, that are particularly sensitive or specific to diagnose sepsis (Levy et al., 2003). This section details the clinical significance and impact of reliable perfusion monitoring in sepsis, as a high morbidity and mortality example.
Figure 1.1: Criteria for SIRS, sepsis, severe sepsis, and septic shock according to the 1991 ACCP/SCCM Consensus Conference. Adapted from: Bone et al. (1992).
1.2.1 Epidemiology of sepsis In general, sepsis occurs in approximately 2% of all hospital cases across Europe and in most developed countries. Sepsis related incidences may occur in between 6 – 30% of all ICU patients, with considerable discrepancy due to the heterogeneity between ICUs (Vincent et al., 2006; Alberti et al., 2002). Between 1997 – 2005, a study in Australia and New Zealand reported 7649 admitted patients having sepsis or septic shock, with an ICU and hospital mortality of 20.9% and 27.6%, respectively (Moran et al., 2007). Table 1.1 shows incidences of sepsis and related mortality reported in several major worldwide studies. However, it should be noted, incidences of sepsis, severe sepsis, and septic shock are less known in the developing world (Adhikari et al., 2010).
27

Table 1.1: Worldwide incidences of sepsis and related mortality as determined in 8 studies.

Study by

Country or countries

Study period

Angus et al. (2001b)
Martin et al. (2003)
Padkin et al. (2003)
EPISEPSIS and Group
(2004) Finfer et al.
(2004)
Silva et al. (2004)
Flaatten (2004)
Hoa et al. (1998)

USA
USA England and
Wales
France
Australia and New Zealand Brazil
Norway
Vietnam

1995 1997 - 2002
1997 2001 1999 2001 - 2002 1999 1993 - 1994

Study design
Examination of state databases Examination of national databases Examination of national databases
Multicenter cohort study
Multicenter cohort study
Multicenter cohort study Examination of national
databases Examination of state databases

Incidences (per 100,000 population)

Mortality (%)

300

29

91

34

51

47

95

38

77

35

614

34

149

14

204

6

Sepsis presents a serious medical problem in the adult ICU, with a 11 – 15% incidence of severe sepsis, 30 – 80% mortality rate, US$22,100 average cost per case, US$16.7B annual total cost, and 1.5% projected annual incidence increase (Angus et al., 2001a; Dellinger et al., 2008). Sepsis patients are typically more severely ill, stay longer in hospital, more expensive to treat, and at greater risk of death when compared to hospitalised patients diagnosed with other medical condition. In one study, the mean hospitalization length of stay and costs for patients with severe sepsis were 16 days and US$26,820, respectively, with 1-year inpatient and outpatient costs totaling US$48,996 (Braun et al., 2004). Figure 1.2 gives an example of the high cost related treatment and low research funding for sepsis in US and Europe, compared to other medical conditions and diseases.

28

Elderly people, aged ≥ 65 years, are at higher risk of being diagnosed with sepsis than younger people (Wester et al., 2013; Starr and Saito, 2014). However, race, ethnicity, and gender may also be associated to the variable risks of developing sepsis (Martin et al., 2003; Mayr et al., 2010; Dombrovskiy et al., 2007). For example, men are typically more susceptible to developing sepsis compared to women (Esper et al., 2006; Martin et al., 2003; Moss, 2005). Other studies claim people of black origin are at the highest risk of developing sepsis followed by other non-white and white origins (Esper et al., 2006; Barnato et al., 2008), although they have been contradicted by a more recent study (Moore et al., 2015).
Figure 1.2: Sepsis having the highest number of incidences in US/Europe receiving the lowest amount research funding compared to other medical conditions. Source: Kunz (2012)
Currently, blood cultures are considered the gold standard for confirmation of the infection component of sepsis. However, the culturing process can take between 24 – 48 hours and only 51% of sepsis cases are positively identified by this method, while the others denoted “culturenegative sepsis” (Martin et al., 2003; Carrigan et al., 2004). Biomarkers can aid sepsis diagnosis by producing results in 2 – 3 hours, with varying levels of clinical accuracy (Carrigan et al., 2004).
29

However, biomarkers are yet to be adopted as a standard of care due to low sensitivity and specificity demonstrated in clinical trials (Uzzan et al., 2006; Matson et al., 1991; Chan and Gu, 2011; Drucker and Krapfenbauer, 2013).
Sepsis treatment guidelines and patient management protocols recommend early goal-directed resuscitation of the septic patient during the first 6 hours after infection recognition (Dellinger et al., 2008). Early interventions have been documented to reduce mortality from 46.5% to 30.5% (Rivers et al., 2001). Hence, a rapid, early diagnostic with reasonable sensitivity and specificity could significantly improve diagnosis, care, and outcomes.
1.2.2 Microvascular perfusion dysfunction in sepsis Sepsis fundamentally functions as a disease of the microcirculation, where alterations in microvascular perfusion have been recognized in severe sepsis and septic shock (De Backer et al., 2002), and the severity of these alterations is connected with a poor outcome (Sakr et al., 2004; De Backer et al., 2013). Microvascular dysfunction is a pivotal element in the pathogenesis of sepsis and septic shock, which can lead to reduced tissue extraction of oxygen and organ failure (Trzeciak and De Backer, 2007; Spronk et al., 2004; Ince, 2005). This dysfunction involves all three elements of microcirculation: arterioles, capillaries, and venules (Lush and Kvietys, 2000; Bauer, 2002). Under such circumstances, the microvascular blood flow is altered (De Backer et al., 2002) hampering oxygen transport to tissues in organs (Ince, 2005; Ellis et al., 2002; Bateman et al., 2003). As a result, microvascular tissues become hypoxic, which can result in cellular loss, organ failure, and death.
30

Healthy individuals have a dense network of capillaries with good perfusion. In contrast, septic individuals have a less dense network of capillaries, which is associated with an increase in heterogeneity of perfusion (De Backer et al., 2014). This effect occurs due to the existence of intermittently or not-perfused capillaries in close vicinity to well perfused capillaries (Croner et al., 2006; Secor et al., 2010; Verdant et al., 2009; Farquhar et al., 1996). The reduction in vascular density results in a greater distance for oxygen to diffuse (Bateman et al., 2007). In a large study with 252 septic patients, shown in Figure 1.3, it was seen that capillary density and perfusion was an independent factor associated with survival rate.
Figure 1.3: Relationship between sublingual microcirculation and ICU mortality in 252 patients with severe sepsis. The patients were grouped into quartiles in proportion of perfused capillaries. Source: De Backer et al. (2014).
In addition, sepsis also impairs capillary autoregulation mechanisms. A recent study has shown that impairment of capillary autoregulation is manifested by impaired capillary stopped-flow, increased capillary response time within hypoxic capillaries, decreased oxygen supply rate and
31

decreased RBC oxygen dependent adenosine tri-phosphate efflux (Bateman et al., 2015). This compromise of local microvascular control is partially influenced by increased capillary RBC supply rate and is correlated with increased oxidized metabolites of nitric oxide in blood plasma. Furthermore, these microvascular alterations play an important role in the development of organ dysfunction and are not just an indication of the severity of sepsis.
More importantly and as a result, the heterogeneity of microvascular perfusion during sepsis is associated with alterations in tissue oxygenation and altered oxygen extraction ability. O2E is the quantity of oxygen being absorbed by tissues from circulating blood. In other words, O2E is related to the difference between SaO2 of the blood supplying the tissues and SvO2 of the blood leaving the tissues (Gutierrez and Theodorou, 2012; Vincent and De Backer, 2004; Lifesciences, 2002). In experimental models and studies of sepsis, microvascular flow impairment have, as a result, been shown to impair tissue O2E (Ellis et al., 2002; Trzeciak et al., 2007; Mesquida et al., 2011; Sair et al., 2001). Hence, the ability to assess O2E directly would provide a good surrogate of perfusion and microvascular condition.
1.2.3 Assessment of peripheral perfusion during sepsis Although sepsis causes blood flow alterations in different central regions, several studies reported resting forearm blood flow is relatively high in septic patients compared to non-septic controls (Kirschenbaum et al., 2000; Astiz et al., 1995; Astiz et al., 1991). Peripheral vascular response can be assessed by examining reactive hyperaemia, such as during vascular occlusion tests (VOT), which can provide a measure of the integrity of the microvascular responses to hypoxia.
32

Several studies reported that the response to reactive hyperaemia is attenuated in septic patients during VOTs (Kirschenbaum et al., 2000; Astiz et al., 1995; Astiz et al., 1991; Neviere et al., 1996). Reactive hyperaemia is defined as the transient increase in tissue blood flow, that typically occurs after a brief period of ischemia (Klabunde, 2011). The peak blood flow is decreased during reactive hyperaemia phase in septic patients compared to healthy subjects (Kirschenbaum et al., 2000; Neviere et al., 1996; Astiz et al., 1991; Sair et al., 2001; Astiz et al., 1995), thereby increasing the restoration time of tissues to be saturated with oxygen (Skarda et al., 2007; Neviere et al., 1996).
Hence, failure of the microvasculature to increase blood flow in the face of tissue hypoxia may be associated with compromised vasodilation or a loss of capillary cross-sectional area (Kirschenbaum et al., 2000) and diminished RBC deformability (Astiz et al., 1995). This malfunction is related to the slow rate of tissue deoxygenation during stagnant ischemia in septic patients compared to healthy controls (Mesquida et al., 2011; Pareznik et al., 2006; Sair et al., 2001). Thus, the microvascular response to tissue hypoxia is attenuated in sepsis, as evidenced by a diminution of reactive hyperaemia. The ability to measure O2E and/or local blood flow would capture this attenuation, and thus provide a marker of microvascular dysfunction.
1.2.4 Peripheral blood flow and SvO2 evaluation in sepsis The heterogeneity of microvascular blood flow needs to be accounted when considering compromised oxygen extraction capabilities that occur in sepsis (De Backer et al., 2002). Some studies indicated that peripheral blood flow, especially in the skin, increases significantly during sepsis (Young and Cameron, 1995; Kirschenbaum et al., 2000) accompanied with impaired or low
33

tissue O2E (De Backer et al., 2002; Ellis et al., 2002; Walley, 1996; Doerschug et al., 2007). In addition, a rise in SvO2, due to low O2E, is common during sepsis despite tissue oxygen deprivation (Zaja, 2007; Lifesciences, 2002; Cecconi et al., 2014). Thus, independent monitoring of SvO2 can also serve as an indicator for microvascular dysfunction and reduced O2E in sepsis diagnosis.
However, investigating SvO2, O2E, and blood flow in organs is less feasible than in the periphery, as it typically requires invasive procedures. The currently available literature is unclear about any relationship between peripheral versus core (organ) blood flow and O2E, with progressive severity of sepsis (Di Giantomasso et al., 2003; Chung et al., 2001; Wang et al., 1998; Hart et al., 2003). In particular, the literature is unclear whether high or low organ blood flow and O2E is associated with high or low peripheral blood flow and O2E in septic conditions. Since the reported results are often contradictory, this issue creates an open area of research where this thesis aims to make a contribution by assessing peripheral perfusion in terms of SaO2, SvO2, O2E, and blood flow in the periphery using non-invasive technologies.
1.3 Research overview 1.3.1 Clinical significance of this research This research focuses to develop accurate, continuous, and noninvasive methods that can easily assess peripheral tissue perfusion under clinical conditions. Microcirculatory distress not corrected for 24 hours has been shown to be the single independent factor predicting patient outcome in septic patients (Sakr et al., 2004). Furthermore, there are no established, easy, or non-invasive methods to assess SvO2. Therefore, real-time, low-cost, and non-invasive detection of SvO2, tissue
34

O2E, and blood flow would transform sepsis or cardiovascular disease diagnosis, monitoring and care, by providing an early, real-time measure of a key negative outcome that can be monitored and managed directly. Such a development could significantly aid in early-goal directed therapy in sepsis (Rivers et al., 2001) and circulatory failure.
1.3.2 Research goals In this research, the primary objective is the development of a novel pulse oximeter system that can enable real-time, non-invasive, estimation of peripheral SvO2 and O2E using photoplethysmograph (PPG) signals. It is hypothesized that the peripheral venous bed can be predominantly modulated with respiration-like excitations using a pneumatic pressure cuff and control system, to transform the non-pulsatile peripheral venous system into a pulsatile system. These modulations can be detected by a PPG based sensor and analysis of the relevant spectral component can enable continuous and non-invasive assessment of SvO2, and thus O2E using the PPG derived SaO2.
This research includes hardware and software development of a custom pulse oximeter, design of methodology and experimental protocols, proof of concept testing, and validation of the concept against gold standard comparators in a clinical study. The development of a custom pulse oximeter system that can provide access to the raw PPG signals for processing, unlike conventional pulse oximeters (Shelley et al., 2014), is equally integral to this research for reasons discussed in Section 2.6.
Blood flow change assessment using the PPG signal is second to SvO2 and O2E estimation in this research. A true measure of tissue extraction also needs a measure of blood flow so that flow
35

limited states don’t appear the same as those with higher/normal blood flow (Podbregar and Mozina, 2007). However, current blood flow monitoring methods are reliant on laser or ultrasound based Doppler technologies, which do not provide a measure of oxygen saturation. It is hypothesized that the PPG pulse amplitude can be used to continuously monitor volumetric blood flow changes in peripheral extremities, such as the finger. Equally, an alternate or surrogate measurement for Doppler technologies can be developed using this method, to provide an accurate, reliable surrogate for blood flow.
Parallel to peripheral perfusion monitoring, an independent study was conducted to investigate the effect of temperature on PPG signal quality to ensure robustness of the pulse oximeter system. The success of this research is dependent on obtaining good quality PPG signals for data analysis. Cold skin temperatures at extremities, such as the finger, can severely degrade PPG signal quality and local heating can improve conditions and PPG signal quality, as discussed in Chapter 5. This study thus investigates and quantifies the strength of the PPG signal quality at cold, warm, and normal skin temperatures and their impact on the accuracy of PPG based measurements.
Overall, the main outcome of this research is a novel, robust, low-cost, and non-invasive perfusion monitoring system for SaO2, peripheral SvO2, local tissue O2E, and local blood flow. The results of this research can be beneficial in early diagnosis and management of circulatory and cardiac dysfunctions. Challenges remain with the technology itself, including the standardization of measurements, improving repeatability, and establishing comprehensive normative data ranges for comparison with critically ill patients, preferably septic, and for evaluating responses to diagnostic.
36

1.4 Preface This thesis is separated in two major parts. Part 1, Chapters 2 – 5, discusses the fundamental principles of pulse oximetry and PPG technology, the development of a novel pulse oximeter system, PPG analysis and testing involved, and the effects of different temperatures on pulse oximeter signal quality and measurement accuracy. Part 2, Chapters 6 – 8, discusses application of the novel pulse oximeter system in perfusion monitoring, in particular blood flow change detection and SvO2 estimation, in experimental settings. The following chapters of this thesis are arranged as follows:
Chapter 2: Background and literature review. First, this chapter discusses the fundamental principles of pulse oximetry and PPG, and presents the various applications of PPG. Second, background on perfusion monitoring and its significance in sepsis diagnosis is presented. Finally, the peripheral venous physiology and a review of the shortcomings of available non-invasive methods to assess local SvO2 are discussed.
Chapter 3: Design and development of a novel pulse oximeter system. This chapter presents all the design, hardware specifications, and development of a custom pulse oximeter system that provides access to the raw PPG signals. In addition, the firmware and interface used for PPG data acquisition are also detailed.
Chapter 4: PPG processing and analysis. This chapter introduces the digital filtering environment used to extract useful PPG signals and the methods used to estimate physiological parameters from
37

extracted signals. In addition, it investigates 3 peak detection algorithms used to compute amplitude information from the PPG signals.
Chapter 5: Effect of temperature on PPG signal quality. This chapter analyses the effect of cold, normal, and warm digits on transmittance pulse oximetry, with regards to PPG signal quality and measurement accuracy. In addition, results from a clinical validation study are also included.
Chapter 6: Monitoring peripheral blood flow changes using photoplethysmography. This chapter presents how the PPG signal amplitude can be used to monitor peripheral blood flow changes and its application as a surrogate to vascular Doppler ultrasound technology.
Chapter 7: Estimation of peripheral venous saturation and oxygen extraction using a novel pulse oximeter method. This chapter introduces the development and initial proof of concept testing of a novel respiration-like pulse generation system that can be used to predominantly modulate the venous system. The artificial modulations can be detected by PPG and the spectral components can analysed to estimate SvO2 and O2E.
Chapter 8: Clinical validation trial of a novel pulse oximeter concept for non-invasive estimation of peripheral SvO2. This chapter further investigates the concept in Chapter 7, and the correlation of the PPG based measurements to gold standard measurements. In addition, improvements made to the hardware and development of a new experimental protocol are also discussed in this chapter.
Chapter 9: Conclusions. This chapter summarizes all the outcomes from this research in a nut shell.
38

Chapter 10: Future work. This chapter discusses the potential shortcomings of this research and proposes several improvements that can be made to overcome them.
39

Chapter 2: Background and literature review
2.1 Pulse oximetry and photoplethysmography Pulse oximeters are ubiquitous devices in hospital wards, operating rooms, and intensive care units. They are used to non-invasively estimate arterial blood oxygen saturation and monitor heart rate, and are a standard of care for patient oxygenation monitoring (Ortega et al., 2011; Haynes et al., 2009; Jubran, 2015; Tremper and Barker, 1989). Pulse oximetry uses photoplethysmograph signals produced by an optical sensor, typically mounted on a finger, toe, or ear-lobe, to detect blood volume changes. It is generally accepted that the PPG waveform results from the pulsatile variation in the tissue optical density produced by significant arterial pulsations (Daly and Leahy, 2013; Aoyagi, 2003). Conventional pulse oximetry relies on the pulsatile nature of arterial blood and differential absorption of oxyhaemoglobin and de-oxyhaemoglobin at red (RD) and infrared (IR) wavelengths to estimate SaO2 and HR (Aoyagi, 2003; Mendelson, 1992; Jubran, 2009; Severinghaus, 2007).
Typical transmittance pulse oximeter probes consist of two high output RD and IR light emitting diodes (LEDs) and a sensitive photo-detector (PD). Light energy transmitted through tissue is detected by the PD, which generates the PPG signal. The PPG signal is separated into two parts; the rapidly changing (AC) and the slowly changing (commonly referred to as DC) components. By taking the appropriate AC/DC ratios and calibration values, SaO2 can be reliably estimated (Jubran, 2009; Goldman et al., 2000).
40

2.1.1 History of pulse oximetry In 1940, J. R. Squire was the first to recognize that changes in RD and IR light transmission caused by pneumatic tissue compression permitted oxygen saturation to be computed (Squire, 1940). During the Second World War, Glen Allen Millikhan invented the term ‘oximeter’ for an ear based, light-weight, optical device he developed to continuously measure SaO2 in humans, as part of aviation research (Millikan, 1942). In 1949, Earl Wood used this idea to compute absolute saturation continuously from the ratios of optical density changes with pressure in an ear oximeter (Wood et al., 1950).
In 1972, an electrical engineer at the Nihon Kohden company in Tokyo, named Takuo Aoyagi, was interested in measuring cardiac output non-invasively (Aoyagi, 2003). He was using the dye dilution method using a commercially available ear oximeter and balanced the RD and IR signals to cancel the pulse noise, which had prevented accurate dye washout measurements (Severinghaus, 2007). It was discovered that changes in oxygen saturation voided his pulse cancellation. From this discovery, it was concluded that these pulsatile changes could be used to compute oxygen saturation from the ratio of ratios of pulse changes in the RD and IR wavelengths (Aoyagi, 2003; Severinghaus, 2007). Takuo Aoyagi’s pulse oximeter was improved and successfully marketed by Minolta in 1978, stimulating other firms to further improve and market pulse oximeters worldwide from the mid 1980’s. Notable success of the development of pulse oximetry include reductions in anesthesia-related fatalities by 90% (Severinghaus, 2007), as well as their almost ubiquitous hospital use.
41

In the early 1990s, pulse oximetry became the standard of care for perfusion monitoring during anaesthesia (Allen, 2007), and is now one of the most commonly employed monitoring modalities in the critical care setting. During the past 20 years, several studies focused on the technical aspects of pulse oximeters and concluded that this technology has a good degree of accuracy (Jubran, 2009). This accuracy and non-invasive nature, coupled with the ease of operation, led to the widespread use of pulse oximetry for patient monitoring in hospital units. SpO2 measurement by pulse oximeters has widespread application in many different clinical settings, including operating rooms, ICUs, post-anesthesia care units, and emergency departments (Ortega et al., 2011). Outside clinical settings, SpO2 measurement has significance in sports medicine, domiciliary use, and in veterinary clinics.
2.1.2 Photoplethysmography origin The word “plethysmograph” is derived from two ancient Greek words “plethysmos” and “grapho” which mean “to increase” and “write” (Shelley, 2007; Alnaeb et al., 2007), respectively. Plethysmography is a technique typically used to determine and record variations in tissue blood volume or flow due to heartbeat (Elgendi, 2012). In general, there are 4 different varieties of plethysmography; air plethysmography, impedance plethysmography, strain gauge plethysmography, and photoplethysmography.
Photoplethymography is an optical technique used by pulse oximeters for peripheral blood volume change monitoring and was developed by Alrick Hertzman in 1938 (Hertzman, 1938). Since then, clinicians have widely used photoplethysmography in the study and monitoring of the cardiovascular pulse wave associated with changes in blood volume in the peripheral vascular bed
42

(Roberts, 1982; Dorlas and Nijboer, 1985; Higgins and Fronek, 1986). The convenience, simplicity, and non-invasive nature of this technology have resulted in the dominance of this optical method as a desired technology in several biomedical monitoring situations. PPG fundamentals are detailed in the Section 2.2, since the research presented in this thesis relies on PPG based pulse oximetry.

2.1.3 Pulse oximetry principles The principles of pulse oximetry are based on the differential absorption characteristics of emitted light by oxygenated (HbO2) and deoxygenated haemoglobin (Hb) species. Two separate wavelengths, typically IR and RD, are used to distinguish between the two species of haemoglobin and illuminate the vascular bed. The oxygen chemically combined with haemoglobin inside the red blood cells (RBC) makes up for the majority of the oxygen present in the blood. Functional SaO2 is defined as the ratio of oxyhaemoglobin to the total concentration of haemoglobin present in the arterial blood stream:

2

=

   ℎ

=

2 2 + 

(2.1)

Figure 2.1 shows the extinction coefficients as a function of wavelengths of these two types of haemoglobin. The extinction coefficient relates to the strength of light absorption by haemoglobin at a given wavelength, per mass density or per molar concentration. The typical wavelength band for RD is 600 – 750 nm and for IR is 850 – 1000 nm.

43

At the isosbestic point (approximately 806 nm), both HbO2 and Hb have the same extinction coefficients, and thus absorption. Oxygenated haemoglobin greatly absorbs IR light, while allowing more RD light to pass through. In contrast, deoxygenated (or reduced) haemoglobin absorbs more RD light, while allowing more IR light to pass through. The values for RD and IR wavelengths are chosen such that the absorption by the two haemoglobin species is significantly different at the two points.
Figure 2.1: Absorption spectra of the four types of haemoglobin, showing the extinction coefficients (Lmmol-1cm-1) at red and infrared wavelengths. Reproduced from Tremper and Barker (1989).
The amount of light absorbed is proportional to the Hb concentration in the blood vessel. Thus, the greater the Hb per unit area of the vessel, the greater is the amount of light is absorbed. This property is described by “Beer’s Law” (Miller et al., 2009). The following section details the application of this law in pulse oximetry.
44

2.1.4 Beer-Lambert model The basic mathematics of pulse oximetry can be derived through an algebraic manipulation of the Beer-Lambert model (Webster, 2002). This spectroscopy principle considers how light intensity exponentially decreases as it passes through non-scattering, light-absorbing tissues comprised of one or multiple components. The intensity of light passing through the medium decreases exponentially with respect to distance, in accordance to the following equation (Tremper and Barker, 1989):

Where:

 = −(λ)cd

(2.2)

 Iin is the incident light intensity  Iout is the transmitted light intensity  ε is the extinction coefficient of the absorbing substance at a specific wavelength λ  c the concentration of the absorbing substance, which is constant in the medium  d is the optical path length through the medium

Thus, taking the ratio of the transmitted and incident light at the two wavelengths gives:



=

(⁄)λ1 (⁄)λ2

(2.3)

The modulation ratio (R), a ratio of ratios, is defined as the ratio of the absorbance of blood at the two illuminating wavelengths. SaO2 may be determined from the measured R and knowledge of extinction coefficient of haemoglobin species using:

45

2

=

[2 (λ2)

(λ1) − (λ2) − (λ2)] + [(λ1)

−

2 (λ1)]

×

100%

(2.4)

Where εHb is the extinction coefficient of reduced haemoglobin and εHbO2 is the extinction coefficient of oxygenated haemoglobin. Early pulse oximeters used this concept to operate, as it was originally engineered by Aoyagi and Miyasaka (2002) in the first generation of pulse oximeters. However, in reality, human blood is a highly scattering medium (Roggan et al., 1999; Mannheimer, 2007). Thus, the photons in the transmitted beam of light will not travel all in a straight path before reaching the PD. The actual path length of the detected light is a complicated function of both the scattering and absorption properties of the tissue medium (Mannheimer et al., 1997). Since it was proven that light no longer travels in a straight path, conventional pulse oximetry cannot completely rely on the Beer-Lambert model.

2.1.5 Empirical calibration to determine oxygen saturation Modern pulse oximeters use a calibration function to correct for errors due to scattering. A test pulse oximeter is calibrated against whole arterial blood gas data, measured from healthy, normothermic, human subjects, during in vitro clinical studies (Schnapp and Cohen, 1990; Webster, 2002). The effective haemoglobin extinction coefficients are usually based upon an empirical calibration through the employment of induced hypoxia experiments (Kamat, 2002; Schnapp and Cohen, 1990). Hence, errors encountered due to the assumptions implicit in the Beers-Lambert model are able to be corrected.

Figure 2.2 shows a typical pulse oximeter calibration curve versus the Beer-lambert model, depicting the relation between the ratio of ratios (R) and measured SaO2. The Beer-lambert model
46

is an exponential curve representing the exponential decrease of transmitted light as it passes through layers of light absorbing tissue medium, not considering any light scattering by the tissues. The Empirical Calibration model has a curve between R = 0.5 – 1.25 as a result of modulation ratio derived from Oxygen Saturation: 100 – 70% during hypoxic experiments. However, the data in the range of R = 1.25 – 2.5 is linearly extrapolated from the experimental data.

Figure 2.2: Typical pulse oximeter calibration curve also showing the Beer-Lambert Model. Source: Ross (1999).
To relate the estimated R values to the pulse oximeter’s reading, the equation of the theoretical calibration curve based on Beer’s law can be modified as Mendelson and Kent (1989) defined:

2

=

2

=

1 3

− −

2 4

(2.5)

47

In Equation 2.5, the extinction coefficients from Equation 2.4 are replaced by constants k1, k2, k3, and k4, which are calculated from clinical studies to provide the curve a best fit to the in vitro measured data (Webster, 2002). The term SpO2 means the SaO2 estimate determined by pulse oximetry (Philips, 2003).
Pulse oximetry determines SpO2 by illumination of RD and IR light through vascular tissue, with rapid switching between two separate light sources. AC signals of RD and IR PPG are sensitive to changes in SpO2 because of the variance in the light absorption of HbO2 and Hb at these two wavelengths. Using the AC signal’s amplitude ratio and corresponding DC components for each wavelength, Equation 2.3 can be transformed to calculate R value using:

 = (/)⁄(/)

(2.6)

Since the absolute intensity of the transmitted beam is not known, the transmitted RD and IR signals are normalized by dividing the pulsatile transmitted light (AC component) by the nonpulsatile transmitted light (DC component) (Goldman et al., 2000). This normalization also accounts for light path length variations through the measured tissue. Equation 2.5 can be simplified and SpO2 can be easily calculated as a linear function of R (Mendelson, 1992):

02 = 1 + 2

(2.7)

Where, K1 and K2 are constants derived from the calibration curve (Webster, 2002; de Kock and Tarassenko, 1993; Sinex; Mendelson, 1992; Yang et al., 1998).

48

2.1.6 Calibration free methods of SpO2 estimation Several studies developed methods to compute SpO2 independent of any calibration. Recently, a calibration-free method based on two wavelengths that are close to each other, 780 and 808 nm, was reported (Nitzan and Taitelbaum, 2008; Nitzan et al., 2014a). When the wavelengths are less different, the effective optical path-lengths differences and blood concentration change are also small (Nitzan et al., 2000). These studies developed a model that utilizes R value and haemoglobin extinction coefficients to estimate SpO2:

2

=

1 − 2 (2 − 2) + (1 − 1)

(2.8)

Where εo and εd are extinction coefficients for HbO2 and Hb, respectively, which are available in literature (Wieben, 1997; Mannheimer et al., 1997; Laing et al., 1975).

Reddy et al. (2011) developed a model based on light attenuation to estimate SpO2. They demonstrated that, after applying the natural logarithm, the AC components alone are sufficient to compute SpO2 values without the need for any calibration constants derived from data obtained from volunteers. Their model used the peak to peak values of the AC signal and published haemoglobin extinction coefficients (Wieben, 1997; Mannheimer et al., 1997; Laing et al., 1975) to estimate SpO2:

2%

=

(̂

−

̂ − ̂ ̂) + (̂

−

̂  )

×

100%

(2.9)

49

Where, VRD and VIR are peak to peak values of the AC component for the RD and IR signals, respectively. Although their method used available extinction coefficients, similar to Nitzan and Taitelbaum (2008) model, they did not require any R-value estimation. However, these calibration free models are not used in this research due to the lack of reliability and robustness as discussed in Sections 2.7.4 and 4.4.2.
2.2 Photoplethysmography signal and modes 2.2.1 PPG signal components PPG systems distinguish between light absorption due to blood volume and that of other tissue constituents by considering arterial blood to be dynamic (pulsatile), while everything else is considered static (non-pulsatile). Therefore, there are two components in the PPG signal: the AC component due to pulsatile arterial blood; and the DC component due to non-pulsatile blood, tissues, and bones. The AC component is related to high frequency signals (>0.5 Hz) and is synchronous with HR. In contrast, the DC component is related to very low frequency signals (<0.5 Hz) and captures the slowly varying tissue absorption and light scattering. The PPG signal components and light absorption by vascular bed are illustrated in Figure 2.3.
The AC portion of the PPG arises due to cardiac activity pulsating arterial blood in the vasculature. The frequency components of the AC signal can vary, depending on the heart rate of the individual. This AC signal is superimposed on a large and relatively static DC signal, which is related to average non-pulsatile blood volume and tissues. The DC signal varies very slowly due to respiration, vasomotor activity, and thermoregulation, among other factors (Nitzan et al., 1998). Depending on the physiological state of the microvascular bed, the pulsatile component accounts
50

for a small percentage (approximately 0.05 – 1%) of the total light intensity, either transmitted through or back scattered from the tissue or skin (Mendelson and Ochs, 1988).
Figure 2.3: Dynamic light absorption of vascular bed during cardiac cycle. Source: Tamura et al. (2014).
2.2.2 PPG waveform and shape The PPG waveform results from the time-varying amount of blood pushed into the arterial vascular bed during systole and diastole of the heart’s cardiac cycle. A typical PPG waveform is shown in Figure 2.4. During systole (anacrotic phase), the blood volume in the arteries increases, increasing light absorption and thereby reducing the received intensity. This phase is seen as an ascending limb on a PPG wave. During diastole (catacrotic phase), the blood volume in the arteries decreases, thus reducing light absorption and increases received intensity. This phase is seen as a descending limb on the PPG. Thus, the PPG signal appears pulsatile in nature with this pulsatility matching the HR. On clinical monitors (and Figure 2.4), the PPG waveform is always displayed inverted so that
51

it agrees with the movement of the arterial pressure waveform, increasing in systole and decreasing in diastole, and is thus simply interpreted (Alian and Shelley, 2014; Jonsson, 2006).
Figure 2.4: A typical PPG waveform pulse showing some features.
A characteristic notch is typically visible in descending limb of a PPG pulse (Murray and Foster, 1996; Jubran, 2015; Allen, 2007), and is due to pressure wave reflection at bifurcations of the arterial tree (Sherebrin and Sherebrin, 1990). This notch resembles the dicrotic notch feature seen in an aortic pressure waveform, indicating the closure of the heart’s aortic valve, which causes a similar interruption to flow. This dicrotic notch feature is labelled in Figure 2.4.
52

2.2.3 Transmission and Reflectance mode photoplethysmography PPG signals can be acquired by a sensor in either transmission (TPO) or reflection (RPO) mode, as shown in Figure 2.5. In TPO mode, light transmitted through the tissue is detected by a PD on the opposite side of the LED source. TPO sensors are capable of obtaining a relatively strong signal, across the whole transmitted path length. This high signal-to-noise ratio (SNR) is mainly due to a larger fraction of the emitted light reaching the PD. However, in this mode the measurement site is limited to a few locations, such as the fingertip, earlobe, toe, and tongue, where transmitted light can be easily detected in order to be effective (Tamura et al., 2014).
Figure 2.5: Transmission vs Reflection mode photoplethysmography
In RPO mode, the LED source and PD are placed adjacently on the same side, allowing the PD to detect the light that is back-scattered or reflected from the tissue. This mode provides much more flexibility with sensor placement, and a variety of measurement sites can be used, such as the forehead, chest, and forearm, which are not possible with TPO. In RPO mode, a small fraction of the emitted light reaches the detector, and is mostly scattered, which results in low SNR and pulse
53

amplitude (Dassel et al., 1997). This shortcoming can make RPO sensors much more prone to motion artifacts and pressure disturbances (Tamura et al., 2014). In addition, the path length in RPO mode is much shorter than that in TPO mode as it uses low power LED, thus can provide less in depth information. (Huang et al., 2011).
2.3 Applications of PPG and its limitations SpO2 measurement has been the predominant application of PPG technology in clinical settings. However, the PPG signal is rich in physiological information (Shelley, 2007), and can be used in monitoring of various physiological parameters. Other examples of PPG based assessments include blood flow and perfusion monitoring, heart rate variability, cardiac output and pulse transit time, blood pressure, and systemic and peripheral resistances. In addition, PPG can also be used in clinical diagnosis, such as vasospastic conditions and vascular diseases. This section briefly reviews each of these areas to demonstrate the widespread dominance of this optical technology in medical science, and thus its considerable potential for further innovation and application.
2.3.1 Blood flow and perfusion monitoring Non-invasive assessment of blood flow changes in muscle and bone using PPG has been previously reported (Bergstrand et al., 2009; Naslund et al., 2006; Zhang et al., 2001). These studies showed that the AC component of the PPG corresponds to blood flow, while the DC component corresponds to the blood volume change. Monitoring AC pulse amplitude can reliably estimate blood flow changes at different locations.
54

Perfusion Index (PI) is a relative assessment of the PPG pulse strength at the monitoring site, and can be used as an indicator of perfusion (Masimo, 2007). PI is measured as a ratio of AC to DC components of the IR signal, corresponding to the pulsatile and the non-pulsatile amounts of blood. Lima et al. (2002) demonstrated that the PI measurements can be used to non-invasively monitor peripheral perfusion in critically ill patients. Another study reported that the PI can accurately indicate sympathectomy-induced vasodilatation that can affect perfusion (Ginosar et al., 2009).
2.3.2 Heart rate variability The distance between two systolic peaks (peak-peak interval) can be used to reliably monitor HR (Fu et al., 2008; Cennini et al., 2010). In addition, this PPG feature can also be used to estimate heart rate variability (HRV) overtime. Several studies compared HRV derived from R-R intervals in electrocardiogram (ECG) signal to HRV derived from PPG pulse interval and peak-peak interval in healthy cohort and hospital patients (Chuang et al., 2015; Selvaraj et al., 2008; Gil et al., 2010). All of these studies found a strong correlation between the HRV’s calculated from the two methods. Another study showed that the PPG pulse interval can also be used to determine HRV (Lu et al., 2008). HRV determined from PPG signals can be a potential surrogate for its ECG counterpart (Gil et al., 2010; Chuang et al., 2015), due to the simpler measurement procedure and ease of access, since PPG devices uses only one probe to record the complete waveform.
2.3.3 Cardiac output and pulse transit time Cardiovascular monitoring is not only essential for hospitalised critically ill patients, but also for patients at home and those undergoing cardiopulmonary exercise testing. Wang et al. (2010) developed a tube model that can derive a cardiac output (CO) index, based on the pulse time
55

reflection ratio (PTRR) from an electrocardiogram and PPG based measurements. With appropriate calibration, the PTRR can be used to estimate beat-to-beat CO. Lee et al. (2013) extracted spectral and morphological features from a finger based PPG sensor, and added to HR and mean arterial pressure as input features to a multivariate regression model to estimate CO and systemic vascular resistance. They developed a stepwise feature search algorithm to select statistically significant features. Myint et al. (2014) used PPG sensors at finger and wrist to measure pulse transit time (PTT), which is the time between the two maxima of two PPG waveforms at two sensor locations. PTT is derived from the difference between the wrist PPG sensor and the finger PPG sensor, by calculating the arrival time’s difference of a corresponding point of identity on each of the PPG waveforms.
2.3.4 Blood Pressure estimation Nitzan et al. (2009) presented a pressure cuff based technique for automatic measurement of systolic blood pressure, based on simultaneous measurement of PPG signals from fingers of both hands. They inflated a pressure cuff to a level above systolic blood pressures at a relatively slow rate, resulting in loss of PPG signal. The pressure cuff was then deflated, and the pressure at which the PPG signal reappeared was taken as the systolic blood pressure. Their results agreed well with sphygmomanometry measurements. In contrast, Song et al (Song et al., 2009) demonstrated that both the systolic and diastolic blood pressure can be estimated by studying the changes in morphology of the PPG , using a similar pressure cuff method.
56

2.3.5 Peripheral and systemic resistance assessment The PPG pulse width and area has been previously used to determine peripheral and systemic resistances. Awad et al. (2007) reported that the pulse width of finger and ear PPG tracings correlates well with changes in systemic vascular resistance, (r = 0.56 and 0.62, respectively). In another study, (Wang et al., 2009) split the pulse area at the dicrotic notch, and found that the ratio of the two areas as a potential indicator of total peripheral resistance. This ratio is called the inflection point area ratio.
2.3.6 Aging and vascular disease assessment PPG technology can be clinically important in aging and vascular disease assessment. Yousef et al. (2012) reported that parameters derived from PPG contour analysis have a close relation with age. Aging affects the contour of PPG signals which accelerates the disappearance of PPG’s dicrotic notch and PPG’s inflection point as well. Peripheral arterial diseases, such as vascular atherosclerosis, prevail with the increase in age and can result in the occlusion of the arteries. Under such diseased conditions, the PPG pulse usually becomes damped, delayed, and diminished with increasing severity of disease (Heck and Hall, 1974; Osmundson et al., 1985; Kvernebo et al., 1989), and thus can be diagnosed using PPG (Shelley and Shelley, 2001). In addition, PPG signal derivatives can be useful in vascular disease determination. Alty et al. (2007) demonstrated that the peak-peak interval, crest time, and stiffness index derived from the first derivative of the PPG were ideal features for cardiovascular disease classification.
57

2.3.7 Vasopastic conditions assessment PPG sensors have been previously used to investigate vasospastic or cold sensitivity condition called Raynaud’s phenomenon. Cooke et al. (1985) characterized the PPG pulse shape in healthy subjects and Raynaud’s patients and found that both the pulse amplitude and the slope of the rising edge are good markers for the condition. Loss of the PPG dicrotic notch in affected patients secondary to systemic sclerosis was also reported, in association with reductions in vessel compliance. Variation in pulse amplitude with cold exposure have shown prospects for diagnosing ‘vibration white finger’, also known as hand arm vibration syndrome, using multi-channel finger based PPG assessments (Dyszkiewicz and Tendera, 2006).
2.3.8 Limitations Conventional pulse oximetry may provide erroneous readings due to poor signal strength (low SNR), resulting from many physiological conditions, such as low perfusion, skin temperature, vasoconstriction, and skin pigmentation (Feiner et al., 2007; Khan et al., 2015a; Njoum and Kyriacou, 2013; Sinex, 1999; Talke and Stapelfeldt, 2006; Fouzas et al., 2011). Poor peripheral perfusion triggered by clinical conditions, such as hypovolaemia, hypothermia, and vasoconstriction during surgery, may result in pulse oximeter error or failure (Kyriacou et al., 2002). These clinical conditions often arise due to the administration of anaesthetic agents and/or muscle relaxants (Nakajima et al., 2000). Other external circumstances can also reduce SNR of pulse oximeter, such as motion artefacts, electromagnetic interferences, environmental noise, strong ambient light, and finger nail polish (Fluck et al., 2003; Hanning and Alexander-Williams, 1995; Petterson et al., 2007; Sinex, 1999; Fouzas et al., 2011; Hartmut Gehring et al., 2002). All these limitations can result in inaccurate SpO2 readings and/or cause false alarms.
58

In addition to the physiological drawbacks, conventional pulse oximetry has several design limitations. Being highly dependent on the pulsatile component of the PPG restricts its operation to SaO2 assessment and cannot measure SvO2. Typical pulse oximeter derived waveforms presented to the clinician are highly filtered and processed from the original PPG signal. Manufacturers use adaptive noise reduction-based signal conditioning and advanced digital signal processing techniques (NTS, 2011), which enable separation of sources and noise signals (Goldman et al., 2000; Bennett, 1998; Rheineck-Leyssius and Kalkman, 1999). Thus, with minimum access to the raw PPG waveform and the overriding clinical importance of monitoring oxygen saturation, various other potential uses for the PPG waveform have been largely neglected or not possible (Shelley et al., 2014).
In conventional pulse oximeters, the process of amplifying the AC signal for a clearly detectable pulse, removes bulk of the DC component. Complex algorithms are used to evaluate the shape of each potential pulses and extract useful pulses from noisy signals (Rheineck-Leyssius and Kalkman, 1999; Bennett, 1998). While such signal processing may help in SpO2 estimation, it often compromises valuable physiological information. Preservation of the DC signal in the raw PPG has the potential to enable other parameters, such as SvO2, to be determined. Thus, the development of a pulse oximeter system, which gives access to both the raw and amplified signal, is a necessary part of extending potential uses and for perfusion assessment in this research.
2.4 Venous physiology and SvO2 assessment Arterial oxygen saturation, SaO2, can be reliably determined using non-invasive pulse oximetry due to the pulsatile nature of arterial blood. SaO2 is a global parameter, and thus the body’s
59

regulatory systems maintain the same systemic and peripheral saturation levels. In contrast to SaO2, peripheral SvO2 is different to central SvO2 due to the difference in oxygen demand and consumption between peripheral and central tissues. Neither peripheral nor central SvO2 can be determined using conventional pulse oximetry.
If regional SvO2 can be reliably estimated non-invasively, the degree of local O2E can also be determined from the difference to SaO2. This difference would reflect, at least locally, the adequacy of regional tissue perfusion. In addition, SvO2 has been reported as an early indicator of increased oxygen consumption and inadequate oxygen delivery in patients undergoing cardiac surgery (Kamshilin et al., 2015), further validating the potential of this measure. This section discusses the venous physiology and the currently applied or investigated methods used to assess SvO2.
2.4.1 Physiology of peripheral venous compartment In the peripheral regions, venous blood exhibits a non-pulsatile, constant flow. As arteries lead to arterioles and capillaries, the resistance to blood flow decreases due to a significant increase in the total cross sectional area (CSA) of the vasculature before entering veins (Patton, 2015). The reduction in peripheral resistance has been associated with the transition from pulsatile flow in the arteries to constant flow in the veins (Walton et al., 2010). In addition, the venous pathways linking peripheral veins with the heart are interrupted by series of valves. These valves significantly attenuate the retrograde pressure waves emerging from the right heart (Walton et al., 2010; Caro et al., 2012), which thus prevent any natural pulsation in the peripheral veins. Therefore, conventional pulse oximetry cannot estimate SvO2 since the technology relies on the pulsatile nature of blood.
60

2.4.2 Methods to assess tissue perfusion and SvO2 Current methods of measuring peripheral SvO2 in clinical settings involve fibre optic catheterization, such as peripheral IV catheters or via direct blood draw (Bloos and Reinhart, 2005), both of which are intrusive and come with risk of complications. Previous studies have shown that peripheral perfusion can be assessed non-invasively under clinical conditions using technologies such as laser Doppler based blood flow measurements (Briers, 2001; Cutolo et al., 2010; Humeau et al., 2007) and capillary microscopy (Jacobs et al., 1990; Carpentier, 1998), or by monitoring the central-to-toe temperature difference (Vincent et al., 1988; Boerma et al., 2008; Boerma et al., 2005), although these technologies or methods cannot measure SaO2 or SvO2. In contrast, several studies have previously shown that optical technologies, such as near infrared spectroscopy (NIRS) and photoplethysmography can be employed to detect changes in peripheral perfusion and estimate oxygen saturation (Lima et al., 2002; Van Beekvelt et al., 2001; Lipcsey et al., 2012; Nioka et al., 2006; Shelley, 2007).
NIRS is a non-invasive, optical technique that allows determination of tissue oxygen saturation (StO2) based on spectro-photometric quantification of oxygenated and deoxygenated hemoglobin within a tissue. Typically, NIRS sensors use three or more wavelengths to measure StO2. However, the StO2 determined by NIRS devices cannot distinguish between arterial, capillary, and venous blood (Petrov et al., 2012; Colquhoun et al., 2012; Sørensen et al., 2013). As a result, NIRS cannot precisely measure SvO2. Hence, while some NIRS based studies have provided reasonable SvO2 measurements within physiological range (Colquhoun et al., 2012; Franceschini et al., 2002), there are several concerns over their methods and outcomes, which are explicitly discussed in the following section. In addition, it is difficult to assess blood flow continuously using NIRS as it
61

requires vascular occlusion procedures (Lima and Bakker, 2011; Van Beekvelt et al., 2001), that also significantly interrupt care.
Several researchers have previously tried to measure SvO2 in the central vasculature using PPG. Recent PPG studies on the central vasculature have shown that the PPG waveform is influenced by positive pressure ventilation and respiratory variations (Natalini et al., 2006; Phillips et al., 2012; Walton et al., 2010; Wardhan and Shelley, 2009; Cannesson et al., 2007; Nilsson et al., 2003; Leung et al., 2008). Respiratory variations impart a periodic oscillation on the PPG signal, which is dominated by venous blood, rather than arterial blood. (Lynch et al., 2014; Walton et al., 2010; Phillips et al., 2012; Cannesson et al., 2007; Nilsson et al., 2003; Wardhan and Shelley, 2009; Shafqat et al., 2015; Colquhoun et al., 2012). This variable and large pulsatile artefact in the PPG has been analysed to estimate central or peripheral SvO2 using PPG based sensors.
While some of these studies reported a reasonable SvO2 estimate (Walton et al., 2010; Shafqat et al., 2015; Colquhoun et al., 2012), outcome of their study has several concerns, which are discussed in detail in the subsequent section. Equally, none of these methods addressed the measurement of O2E and blood flow, or their significance in determining regional perfusion. Other approaches to non-invasively estimate SvO2 are also discussed in the following section, but these too have significant limitations that do not address all the needs outlined in this chapter.
62

2.5 Existing research into non-invasive methods to assess SvO2 2.5.1 Venous pulsation using mechanical ventilation to assess SvO2 Previous studies investigated the periodic oscillations of PPG signals induced in the thoracic cavity by pressure changes due to mechanical ventilation or normal respiratory cycles (Walton et al., 2010; Phillips et al., 2012; Shafqat et al., 2015). The positive pressure changes were mediated by volume changes in the central venous compartment. These modulated PPG signals were analyzed to evaluate SvO2. However, the methods used in these studies are invasive, and/or required positive pressure ventilation, and/or are not applicable to measurements in the peripheral regions.
Specifically, Walton et al. (2010) used a reflectance PPG sensor in the oesophagus to assess central SaO2 and SvO2 in cardiac surgery patients. They investigated the influence of positive pressure ventilation on the PPG waveform. They extracted low and high frequency components from the PPG signals. Several algorithms were proposed to estimate the ratio of ratios (R value) from the filtered PPG signals in both the time and frequency domains. Median SaO2 estimates were approximately 100% and SvO2 estimates were approximately 80%, while the differences between them were statistically significant (n = 10, p < 0.0071).
In a subsequent study, Shafqat et al. (2015) used the same experimental data and improved the method of estimating instantaneous SvO2 using a smoothed-pseudo Wigner-Ville distribution. A statistically significant difference was found between instantaneous SaO2 and SvO2 estimates (n = 12, p ≤ 0.001). However, both methods required insertion of a PPG probe inside the oesophagus and examined sedated patients undergoing positive pressure mechanical ventilation. In addition,
63

neither study validated their results against a gold standard, such as blood gas measurements of venous blood.
Phillips et al. (2012) conducted a similar study on healthy volunteers, but used a forced respiratory inspiration method. They investigated the effect of negative airway pressure on the blood volume within the tissue bed of the finger, and the subsequent modulation of the PPG signals. Estimated mean SvO2 was determined to be 3.1% (±4.2%) below estimated mean SaO2. The reason for the small difference between the two saturations was suggested to be due to the lack of skeletal muscles in the finger. However, 50% of their SaO2 estimates were below expected values of 95 – 100% for healthy adults. In addition, some of their SvO2 estimates were greater than the corresponding estimated SaO2 values, which is not physiologically possible. Like the prior two related studies, there was also no validation against a gold standard in this study.
2.5.2 Estimation of SvO2 using natural venous pulsation Colquhoun et al. (2012) compared SvO2 measured via NIRS and reflectance PPG with blood gas data from blood samples obtained from the internal jugular vein. Venous drainage of the brain occurs almost exclusively through the relatively superficial internal jugular veins. Being close to the core, it is expected that the venous blood there gets naturally pulsed by respiration. Frequency components due to respiration (approx. 0.2 Hz) and cardiac activity (approx.1 Hz) were identified using FFT. Walton’s ResDC algorithm (Walton et al., 2010) was applied to estimate SvO2 from the PPG signals. NIRS assessed SvO2 showed a weak, but statistically significant, correlation to measured SvO2 (r2 = 0.28, p = 0.03), with a mean bias of 2% and limits of agreement of -15.5% to 19.5%. In contrast, the reflectance PPG measurements showed no statistically significant
64

correlation (r2 = 0.00, p = 0.98), with a mean bias of 4.3% and limits of agreement of -49.8% to 58.3%. They also posed concerns over the blood gas analyzer’s accuracy at low saturations and the penetration depth of reflectance PPG. Thus, they were not able to assess any changes in jugular SvO2 using NIRS or PPG.
2.5.3 External venous pulsation to assess SvO2 Schoevers et al. (2009) developed an artificial pulse oximeter with pulse generation system to modulate the arterial and venous compartments simultaneously at very high pressures of 660 mmHg, which are well above systolic blood pressures. The study used 3 separate digit pressure cuffs, which were sequentially inflated to induce a pulsatile component in the PPG signal by peristaltic action. Their idea was to use Shelley’s arterial to venous compliance ratio (Shelley et al., 2011) to estimate SaO2 and SvO2 from the PPG signals. However, Schoevers et al.’s results were determined to be neither comprehensive nor conclusive in a further study by Cloete et al. (2013). In addition, using a modulation pressure above systolic blood pressure interrupts normal arterial blood flow to the finger. Thus for these reasons, it is also not be possible to make continuous oxygen saturation measurements using this method.
In 2003, (Chan, 2002) developed the Venox concept to estimate SvO2 in the periphery from PPG signal and filed a patent (Chan et al., 2007). This concept used high frequency (7.5 Hz) modulations to rapidly pulse the venous bed at low pressures of 40 mmHg, below typical diastolic pressures and thus not interrupting arterial flow, using a digit pressure cuff. The resulting PPG waveform was decomposed into relevant spectral components based on cardiac (approximately 1 Hz) and pressure cuff (7.5 Hz) frequencies. The rapid pulsations were expected to separately excite
65

the venous bed that can be observed in the PPG signals for SvO2 estimation. Echiadis et al. (2007) implemented the Venox concept in a study with patients undergoing heart bypass surgery. However, their research did not appear to provide data suitable for clinical use, as scrutinized in another study by Thiele et al. (Thiele et al., 2011). The SvO2 determined from the PPG signals was compared to central venous oxygen saturation (ScvO2) measured by a cardiopulmonary bypass (CPB) machine. Since the PPG measurements were peripheral and the CPB provided central measurements, the author reported that it was not possible to infer ScvO2 from PPG assessed SvO2, which is also not the goal in this research. In addition, no SvO2 estimates were specified for healthy human subjects, not allowing any comparison to expected values.
2.5.4 Venous occlusion dependent peripheral SvO2 estimation using NIRS The volume of blood in a venous compartment can be increased by occluding the venous outflow with a pressure cuff, in a given limb. During such procedures, the pressure applied to the pressure cuff is much lower than arterial diastolic pressures to maintain perfusion, but higher than venous blood pressures (approximately 10 mmHg). As a result, blood pools in the venous compartment, increasing the venous blood volume. The spectral absorbance can be compared before and after venous occlusion at two or more wavelengths to assess SvO2 in the venous compartment. Previously, researchers used NIRS and PPG technology to demonstrate this approach (Yoxall and Weindling, 1997; Nitzan et al., 2000).
Yoxall and Weindling (1997) compared the SvO2 measured via NIRS with that obtained by cooximetry, an in vitro reference measurement method, and venous occlusion on blood samples drawn from superficial veins. A significant correlation between the two measurements was
66

reported (n = 19, r2 = 0.49, p < 0.0001). However, the linear correlation explained only 50% of the observed trends. They observed a systematic bias dependent on the lateral spacing between the light source and photo detector, adjacently positioned in RPO mode. It was concluded that the more distant the source and detector, the deeper light beams can travel, allowing detection of more desaturated blood or lower SvO2.
Nitzan et al. (2000) used two wavelengths close to each other, at 767 nm and 811 nm, and near to the isosbestic wavelength of 805 nm to measure SvO2 via NIRS and venous occlusion. This choice of wavelengths can reduce the error of neglecting the difference in scattering constant between two wavelengths (Mannheimer et al., 1997), In addition, the difference of the effective optical path length and of the blood concentration change between the two wavelengths can be neglected. NIRS at the hand and finger of healthy volunteers (n = 17) resulted in mean SvO2 values of 86.2% (±4.1%) and 80% (±8.2%), respectively. They modified an available SaO2 model involving hemoglobin extinction coefficients to make these saturation estimates, as discussed in Section 2.1.6.
The venous occlusion technique used in both of these studies has two common downsides. First, continuous SvO2 measurements cannot be made, since the method relies on discrete interventions isolated by sufficient time for the tissue to reach equilibrium. Second, prolonged disturbance to the venous compartment may lead to potential complications, such as venous stasis and venous thrombosis (Eberhardt and Raffetto, 2005), as well as interference to any intravenous access in clinical settings. Although Nitzan et al’s SvO2 estimates fall within reasonable physiological ranges for healthy subjects, the mean SaO2 estimate of 94.5% (±3.0%) was below the expected
67

range of 95 – 100% for healthy subjects. This inaccuracy thus also questions the reliability of the SvO2 estimates obtained with that sensor.
2.5.5 Peripheral SvO2 estimation using NIRS Franceschini et al. (2002) used 6 different wavelengths in a NIRS sensor and natural respiration induced oscillations of near infrared absorption in tissues to estimate peripheral SvO2. Experiments included investigations in the hind legs of pigs (n = 3) and upper thigh of human subjects (n = 8). Their study involved complex data processing and analysis to estimate SvO2. First, they computed the amplitude of absorption oscillations at the respiratory frequency at each wavelength. Second, the spectrum of the absorption amplitude was fitted with the hemoglobin absorption. In addition, the effective optical path length from the light source to the light detection point was determined, which is dependent on a frequency-domain multi-distance method (Alberti et al., 2002). Outcomes from the pig experiment showed good agreement between blood gas data and NIRS estimated SvO2 values, with a mean difference of 1% (±5.8%). In addition, outcomes from the human experiments showed good agreement between NIRS estimates of SvO2 from natural peripheral pulsation to those obtained using venous occlusion method, with an average deviation of 0.8% and maximum discrepancies of 24.2% and 15.8%.
However, there are several concerns about this study. No whole blood sample was taken from human subjects for blood gas analysis and comparison of estimates, and there was thus no reference standard comparator. There are also concerns about the measurements made in human subjects being affected by arterial pulsations, where it is typically recommended that the site of the NIRS sensor be distant from any arteries in proximity, which is not the case in this research.
68

Section 2.3.1 discussed how peripheral venous blood has constant flow, and is typically not subjected to any natural pulsation. Therefore, their study, assumptions, and outcome are contradictory to this information, and are thus not necessarily applicable in extremities like the hand or finger.
2.6 Discussion and integration Available non-invasive methods, using PPG and NIRS sensors, to assess SvO2 have several concerns. Some of these methods provided physiologically realistic SvO2 estimates, but did not validate their results against gold standard measurements and used some invasive procedures (Walton et al., 2010; Phillips et al., 2012; Shafqat et al., 2015). No reference measurement and the invasive nature of these studies makes their method less reliable and less applicable, respectively, in peripheral perfusion monitoring. Colquhoun et al. (2012) could not detect any change in local SvO2 using PPG and NIRS sensors, which is important to determine changes in perfusion. Being able to monitor changes in SvO2 is very important to distinguish between normal and high/low levels of SvO2. In particular, sepsis patients are likely to experience blood flow alterations and significant changes in peripheral SvO2 levels, due to impaired tissue oxygen extraction capability. Two other studies attempted to assess SvO2 using PPG sensors by inducing pulsations to the venous system, but failed to provide a physiologically realistic estimate of SvO2 (Schoevers et al., 2009; Echiadis et al., 2007). Accurate monitoring of SvO2 is integral to consider this parameter as an indicator of perfusion alterations in sepsis diagnosis. In addition, they did not validate their method using gold-standard reference.
69

Yoxall and Weindling (1997) and Nitzan et al. (2000) reported some correlation of SvO2 estimates with reference measurements and physiologically realistic SvO2 estimates, respectively. However, their methods provide a measurement every 40 seconds, and thus continuous assessment of SvO2 is not possible. In addition, their method employs venous occlusion procedures, which if prolonged may harm the vascular bed (Eberhardt and Raffetto, 2005). Finally, the study by Franceschini et al. (2002) showed some good outcomes, although, they did not validate their human subject data using blood gas analysis data. Their NIRS sensor often cannot provide accurate measurements due to artefacts caused by arterial pulsations. Hence, continuous and simultaneous assessment of local SaO2 and SvO2 to determine tissue O2E or perfusion changes is not possible using this method.
Reliable SvO2 monitoring is integral to perfusion monitoring as a necessary measure to determine tissue oxygen extraction capability, and as a clinical marker of microcirculatory failures. In addition to reliability, continuous monitoring of SvO2 can track alterations in tissue perfusion in real-time, as such alterations are very common in sepsis patients. Pulse oximeters can continuously monitor SaO2, and thus continuous monitoring of SvO2 will enable real-time assessment of tissue O2E and perfusion changes. Hence, there is a need of a monitoring system that can provide reliable and continuous and simultaneous measurements of both SaO2 and SvO2, which can lead to improved diagnosis of clinical conditions, such as sepsis.
Conventional pulse oximeters cannot assess peripheral venous blood due to its non-pulsatile nature. Available perfusion monitoring systems cannot reliably and/or continuously monitor SvO2 using PPG or NIRS. This research aims to address these shortcomings of conventional pulse oximeters and available perfusion monitoring technologies in the context of defining the problem
70

and delineating how this research can improve its potential in perfusion assessment, in particular SvO2, using reliable, low cost, and non-invasive pulse oximetry. 2.7 Summary Pulse oximeters are commonly used in clinical settings. They use photoplethysmography to detect changes in blood volume, which can be used to asses SpO2 and HR. SvO2 is a useful parameter to assess perfusion completely, and can be used as a marker in sepsis diagnosis. Conventional pulse oximetry cannot measure SvO2 and other pulse oximeter based methods have several shortcomings, some of which are taken into consideration for the studies presented in Chapters 7 and 8. The following chapter discusses the design and development of a custom built pulse oximeter system, but also some novel technological aspects that are not demonstrated by current commercial offerings, for peripheral SaO2, SvO2, O2E, and blood flow assessment in this thesis.
71

Chapter 3: Design and development of a novel pulse oximeter system
3.1 Introduction Commercial sensitivity has limited access to raw PPG signal data, and thus the rate of new pulse oximeter applications has diminished significantly (Shelley, 2007). Although conventional pulse oximeters use two wavelengths, only the infrared PPG waveforms are typically presented to the user or clinician on screen. In addition, the filtering of a majority of the DC signal removes valuable physiological data, including venous blood absorption information. In this research, the primary goal is to measure tissue oxygen extraction, which is dependent on venous blood oxygen saturation data. Thus, the development of a pulse oximeter system that preserves all the original PPG signals is essential to extend its potential.
A custom pulse oximeter system (PO) was developed to provide access to the raw and amplified PPG signals for both RD and IR wavelengths. The final product meets the technical specification and functionality of a typical pulse oximeter (Markandey, 2010; Webster, 2002). The device provides extra flexibilities, such as control of LED intensity, complete PPG data monitoring, and recording data for post processing and analysis. The design specifications, control mechanics, PPG signal acquisition, and all other parameters of this PO system are presented in this chapter. Details of the PPG signal processing and analysis techniques employed are also included in this chapter.
72

3.2 System Background
The PO system was developed using a CY8CKIT-050 PSoC 5LP (Cypress Semiconductor, San Jose, CA, USA) Development Kit (CDK), as shown in Figure 3.1. This system uses an ARM Cortex M3 microcontroller unit (MCU). The overall design is based on the openly available pulse oximeter implementation on the TMS320C5515 (Texas Instruments, Dallas, TX, USA) DSP Medical Development Kit (Markandey, 2010), and uses the same electronics circuitry.

A. MCU Programmer C. CDK

B. Serial communication D. PO Sensor

Figure 3.1: Hardware circuitry of PO system, along with the sensor

The sensor LEDs transmit RD and IR light through the finger, which is detected by the PD, in a TPO mode application. Light energy received at the PD end is converted to a current signal, which is passed through a transimpedance amplifier. A de-multiplexer extracts the conditioned raw PPG

73

signal from the transimpedance amplifier output, so that the RD and IR PPGs can be processed independently. Separated analog PPG signals are then passed through an analog-to-digital converter (ADC) for logging, storage, and post processing. The block diagram showing the major components of the PO system is presented in Figure 3.2.
Figure 3.2: Block diagram for the PO system.
3.3 Signal Acquisition 3.3.1 Sensor principles A standard transmission mode sensor (model: 320701001, Biometric Cables, Guindy, Chennai, India) is used to acquire PPG data from a finger. The dual LED sensor produces 660 nm and 940 nm wavelength light for the RD and IR modes, respectively, and contains a high sensitivity PD. This pair of wavelengths is widely used in pulse oximeter sensors (Ortega et al., 2011; Mendelson, 2003; Wang and Liu, 2011). The PD is optimized for reliable performance at both wavelengths, and exhibits low capacitance and residual currents (Optoelectronics, 2013). Detailed LED and PD
74

specifications can be found on the manufacturer’s datasheet (Optoelectronics, 2013). The RD and IR LEDs are switched on and off alternately. A switching frequency of 500 Hz with a duty cycle of 29% is used to operate the LED switching, as shown in Figure 3.3. The software on the MCU of the development board controls the switching of the RD and IR LEDs.
Figure 3.3: Sensor LED timing diagram
3.3.2 Intensity control Humans have variable finger thickness and skin color. Thus, every finger will cause a different amount of light absorption and scattering. To compensate for this variation the LED light intensity needs to be adjusted specific to each finger, to optimize light transmission and reception. This section details how the LEDs are adjusted by the MCU of the PO system. The output signal from the transimpedance amplifier is fed to the LED intensity control logic, and is kept within a fixed voltage range of 2.7 – 5.5V to be compatible with the ADC. The intensity control unit sends a feedback signal, based on the raw PPG signal strength, to a digital-to-analog converter (DAC) on the front-end board through the inter-integrated circuit (I2C) bus. This
75

feedback signal is of 12-bit resolution. The output voltage of the DAC is controlled by the MCU to change current through the LED, and thus intensity, using the circuit in Figure 3.4.
Figure 3.4: LED switching and intensity control circuit diagram, where transistors Q1 and Q4 are the controlling the IR LED, and Q2 and Q3 are controlling the RD LED.
Figure 3.5 shows the relationship between the DAC count and the driving LED current. The raw signal received for RD and IR wavelengths are used to control the intensity control of RD and IR LEDs, respectively. The control mechanism automatically increases or decreases the LED intensity to maximise the PPG signal amplitude without saturating the PD, thus maximising the SNR. The LED current is controlled by the DAC driven by the MCU, depending on the RD and IR intensity. The intensity level is thus automatically adjusted with respect to the finger’s thickness and blood flow of the subject.
76

Figure 3.5: Relationship between LED Current vs DAC Count, thus LED intensity characteristics.
The relationship between the DAC count and beam power was validated in a test using a laser power meter (Handheld Laser Power Meter, Edmund Optics, Barrington, NJ, USA). During the test, the pulse oximeter firmware was modified to allow only the red LED to transmit light. The DAC count was increased in steps of 2000 from 19000 to 31000. At each step, the beam strength was measured using the power meter. The same procedure was repeated with the infrared LED. It was observed that the beam power (intensity) increases proportionally with DAC count for at both wavelengths, as shown in Figure 3.6. In addition, the IR radiant flux was found to be much more powerful than the RD radiant flux.
77

Figure 3.6: Relationship between beam power and DAC count for RD and IR LEDs
3.3.3 Signal conditioning Light energy received at the PD is converted to current signals and passed through a transimpedance amplifier circuit for signal conditioning. The transimpedance amplifier is composed of two stages as shown in Figure 3.7. Stage 1 converts the current signal to voltage, and adds a gain of 5 to amplify the output. A 5.1 MΩ feedback resistor converts the input current to an output voltage. Parallel to the resistor, a 2.7 pF capacitor is used to minimize peak gain and improve stability of the signal. This feedback capacitor limits bandwidth, and thus, reduces noise.
78

Figure 3.7: Transimpedance amplifier circuit, where U1 represents Stage1 and U2 represents Stage 2 amplifiers, respectively.
Stage 2 of the transimpedance removes majority the of the DC signal from the raw PPG signal, using a DC correction mechanism highlighted in Figure 3.8, and amplifies the remaining AC signal. The non-inverting input of this amplifier is fed with a DC voltage of ~0.3 V, generated by MCU programmed DAC. This DC voltage ensures the output signal contains the complete AC component within the operational range of the ADC. This amplifier also provides a gain of 5 to the AC component.
Output from both Stage 1 and Stage 2 of the transimpedance amplifier are passed through a demultiplexer, shown in Figure 3.2. The de-multiplexer splits the analog PPG signal to equivalent IR and RD components for independent processing. De-multiplexed analog PPG signals are then sent to the ADC for digitization through 2 separate channels.
79

Figure 3.8: Block diagram showing the LED current control, the transimpedance amplifier stages, and the ADC end of the pulse oximeter’s front-end.
Only the output from Channel 1 of the ADC, shown in Figure 3.8 as ADC CH1, is considered for extraction of the complete DC component from the raw PPG signal during post processing. This channel connects directly to the output of the Stage 1 of the transimpedance amplifier, which contains the raw PPG signal. In parallel, the AC signal is extracted from the amplified PPG signal received at ADC Channel 2, also shown in Figure 3.8 as ADC CH2. The amplified signal provides a more reliable number for post processing of AC signal.
3.3.4 Signal sampling and recording Analog PPG signals are sampled at 50 Hz by a manual mode 16-bit linear ADC, with a 2.5 V reference voltage, on the development board. The PO system’s design can reject 50 Hz mains noise, using several decoupling capacitors. This ability was confirmed during a hardware test, in
80

which no visible 50 Hz noise was detected by an oscilloscope anywhere in the system, including the transimpedance amplifier stage and the ADC input. This test outcome suggests any potential interference or noise from mains at 50 Hz is attenuated by the PO system.
Sampled data are recorded as ADC counts and transferred to the DSP of the MCU using a serial peripheral interface bus. ADC counts can be logged to a PC by a serial communication based interface. All PPG data are stored as text files on the PC, for offline signal processing and analysis in MATLAB (R2014a, MathWorks, Natick, MA, USA).
3.4 Firmware and user interface development 3.4.1 Firmware and Finite state machine development The PO system’s firmware source code was written using the C# programming language (AT&T and Bell Labs, NJ, USA). The source code controls the read/write functionality to/from ADC and DAC channels, LED intensity control, signal conditioning, signal transmission and streaming output from the ADC as schematically shown in Figure 3.9. A finite state machine (FSM) was developed and implemented to the firmware to enable LED intensity control.
Figure 3.10 shows a flowchart of all the states and transitions of the FSM. More specifically, the FSM allows two types of intensity adjustment; automatic and manual. In the automatic mode, the LED intensity is automatically adjusted according to the finger’s thickness and blood flow using a control algorithm. In contrast, the manual mode allows the user to set the LED intensity value, which enables repeatable measurements to be made with the defined intensity.
81

Figure 3.9: PO system firmware top level block diagram.
Figure 3.10: FSM states and transitions for LED intensity control
82

3.4.2 Pulse oximeter user interface A majority of the PPG data presented in this thesis was acquired using open source serial communication software, such as HyperTerminal. However, such method of PPG data acquisition had several drawbacks. The typical serial interface does not provide any real time monitoring of the PPG waveform or timing feature. Thus, simple test errors were not found until after one or many data sets had been post-processed. Hence, the need for easy operation and real time signal monitoring of the PO system was essential.
To improve PPG data acquisition and operation, a graphical user interface (GUI) interface was developed in LabVIEW. The front panel of this GUI is composed of 4 tabs to simplify operation and display:
1) Configuration – Set communication (COM) port, control LED intensity, record the PPG data (default is text file format), and view the streaming data in different channels as in terminal software.
2) Monitoring – Monitor red and infrared PPG waveforms (AC, Raw, and DC signals), SpO2 and HR, and data recording run-time.
3) Protocol timing and notes - Record the start and end time of a protocol, and make notes. 4) Error Indicators – Help to troubleshoot any error that may result while running the
software, such as reading/writing from/to serial port, file processing, and filtering.
The configuration tab allows the user to select automatic or manual intensity control and set up serial communication. The following COM port settings are used to configure serial communication:
83

 COM port: Identified from the computers Device Manager application  Baud rate: 57600  Data bits: 8  Parity: None  Stop bits: 1  Flow control: Hardware
Figure 3.11 illustrates the various features of the GUI using a flowchart. The GUI takes a complete line of 16-bit integer (50 characters long) PPG data and stores them in an array. The array contains 8 columns representing RD and IR component data as; RD intensity, RD raw signal, RD DC offset, RD amplified data, IR intensity, IR raw signal, IR DC offset, and IR amplified signal. A circular buffer is used to store the array for processing and collecting new array samples.
Real time filtering removes noise from the raw PPG but extracts the AC and DC components. Extracted AC and DC components are used to determine instantaneous SpO2 and HR in real-time, using the peak detection algorithm and R value calculation discussed in Chapter 4. Displaying of such important parameters helps to identify the subject’s perfusion and cardiovascular status but also the PPG signal quality.
A screen shot of the monitoring tab in the front panel of the GUI is shown in Figure 3.12. This tab displays PPG signals and calculated parameters in real-time, and also enables identification of weak PPG signals. Without real time waveform monitoring, it is not possible to determine whether the data recorded is of good quality until later post-processing. Real-time monitoring of PPG parameters is helpful when recording several hours length of PPG data, such as during clinical trials as discussed in Chapter 8.
84

Figure 3.11: Flowchart for the PPG acquisition and monitoring GUI
85

Event logs feature in the Protocol timing and notes tab can be used to mark the start or end time of a particular protocol/test, to capture PPG data separately for that protocol/test, and also to easily separate PPG data between tests and/or subjects. In summary, this interface overcame all the short comings of open source serial communication software, while providing additional benefits, and was thus used during later studies (Chapter 6) and the clinical validation trial (Chapter 8). Photos for the other tabs are provided in the Appendix 3.1.
Figure 3.12: Pulse oximeter LabVIEW GUI, showing the monitoring tab in the front panel
86

3.5 Summary Light energy detected by the PPG sensor is converted and conditioned by the PO system to a relative voltage signal. IR and RD signals of the raw and amplified PPG are processed and acquired separately. All analog PPG signals are sampled at 50 Hz, and interfaced to a PC via serial communication. The GUI presented in this chapter allows logging, real-time monitoring, and storing of PPG data for post processing. A FSM was developed for automatic or manual intensity control of the sensor. In addition, the GUI determines real-time SpO2 and HR, from filtered AC and DC values using methods which will be discussed in the next chapter. Hence the system design presented covers the full technological functionality and how it captures all current PPG monitoring functions. This chapter presents the basic design and specifications of the custom pulse oximeter system used in this research. The end product is a complete PPG acquisition and monitoring system. However this chapter does not discuss the additional modifications done to the PO system and equipment used to asses SvO2 and O2E, which are unique and will be covered in later chapters.
87

Chapter 4: PPG processing and analysis
4.1 Introduction PPG data acquisition using the PO system is followed by post processing of the complete PPG data in an offline environment. This procedure is important for comprehensive analysis of patient data and to identify variations in PPG based measurements and their impact, in particular, since the PPG signal can be affected by physiological or external influences. This chapter introduces the post processing, methods, filter design, implementation, filtering, and signal processing involved to extract the AC and DC signals from the sampled raw and amplified PPG data. In addition, the methods and analysis used to estimate SpO2 and HR parameters from the AC and DC signals are also presented in this chapter.
A two stage filter system was designed and implemented to extract the AC and DC signals from the amplified and raw PPG signals, respectively. Three peak-trough detection algorithms were investigated and compared to extract amplitude information from the filtered PPG signals. Modulation ratios of PPG signals, R values, are calculated from the extracted amplitude information with respect to the DC offset signal, and applied to mathematical models to estimate SpO2. In addition, time and frequency domain methods were used to assess HR over time from the AC signals of the PPG, which are also discussed and compared in this chapter.
88

4.2 Data and signal processing 4.2.1 Processing interface A PPG data processing function was developed in MATLAB. The function organizes the PPG data by checking file content of the raw data folder, determining existing files in the directory, making an identical copy of the name for the processed files, and importing the raw data for processing. A text processing function is also incorporated to the PPG script to remove any corrupt data. The module identifies and removes any data line that is not in the expected format. A data line is a set of data from the ADC output for one sample time.
The PPG data collected during data acquisition is in terms of ADC counts. Thus, the arbitrary count values are converted to equivalent voltage value, by multiplying with the reference voltage (2.5 V) of the ADC and then dividing by the number of bits, which in this case is 16 bits (216 – 1). All data were also inverted, multiplying by –1, to match visual representation of PPG waveforms in commercial devices. Data processing is followed by filtering, signal processing, data analysis, and plotting. All computed data (MATLAB workspace variables) and figures are automatically saved upon termination of the script.
4.2.2 Filter design and implementation Sampled PPG data are filtered digitally after the data have been imported. The primary advantage of using digital filters is the flexibility to add/remove filters and modify configurations at any time, according to demand. A two-stage digital filter system was implemented for offline processing of amplified and raw PPG signals. MATLAB’s Filter Design Tools (FDATools)
89

application was used to design and test the stability of the filters, as illustrated in Figure 4.1 for the first stage low pass filter as an example.
The first filter stage is used to remove any high frequency noise from the PPG signals, and the second stage is used to extract AC and DC signals from the filtered signals. The sampling frequency for both filtering stages is set at 50 Hz, to be compatible with the ADC’s sampling rates (Sections 3.3.3 and 3.3.4). Zero phase filtering is applied at each filter stage to prevent any phase distortion and maintain PPG waveform shape.
Stage 1 of the two stage filter system consists of a finite impulse response (FIR), equiripple, lowpass filter. An FIR type filter ensures all frequencies in the PPG signal are delayed by the same duration of time, giving a linear phase response (Ifeachor and Jervis, 2002; Diniz et al., 2010), and thus providing a very stable output signal. The equiripple design method is selected to minimise maximum error between the chosen filter response and the digital approximation, since the filter coefficient values are adjusted to create an optimal filter, with ripples of equal amplitude. This filter design technique minimizes the transition width along the stopband and passband ripple using an efficient optimization procedure (Diniz et al., 2010). A 170th order filter with a cut-off frequency of 10 Hz and attenuation of 50 dB effectively remove any unwanted, high frequency noise from the PPG signals (Markandey, 2010), where high frequency is defined as above 10 Hz and practically above.
Stage 2 of the two stage filter system is composed of two parallel infinite impulse response (IIR) Butterworth filters. The IIR filter type provides a sharp frequency cut-off, and thus a steeper
90

transition region, with high PPG signal throughput (Ifeachor and Jervis, 2002; Diniz et al., 2010). The Butterworth design method is ideal to make the passband signals ripple free. One of the IIR filter is an empirically derived 6th order low-pass filter, which extracts the slowly changing DC signals, below a cut-off frequency of 0.67 Hz. The lower threshold of 0.67 Hz is chosen because the HR of any individual will not typically be less than 40 beats per minute (bpm). Therefore, pulsatility effects due to the heart’s pumping blood and cardiac frequencies will be excluded from the DC signal, as desired.
Figure 4.1: Filter design of the first stage low pass filter, which removes high frequency noise from the PPG
91

The second parallel IIR filter is an empirically derived 4th order band-pass filter. This filter extracts rapidly changing AC signals, such as the cardiac frequencies, with pass band frequencies 0.67 – 4.5 Hz. The upper threshold of 4.5 Hz captures HR and harmonics to a maximum of 135 bpm, which is well above the expected HRs for this research. This filter is used to extract AC signals from the both the raw and amplified PPG signals for analysis and comparison.
4.3 Peak-trough detection R values must be determined from the filtered PPG data for SpO2 estimation. Typically, in pulse oximetry, the R value from IR and RD PPG signals is estimated by time domain analysis of PPG signals. Applications of peak-trough detection algorithms on time domain PPG signals are seen in several studies to extract amplitude information (Bagha and Shaw, 2011; Shafique, 2011). Peak detection is also helpful in determination of HR (Allen, 2007; Nakajima et al., 1996). However, detecting peaks and troughs in a PPG signal can be difficult due a number of factors, such as presence of a dicrotic notch, varying signal amplitude, and poor SNR signal. This problem can result in incorrect or loss of AC pulse determination and amplitude calculation, and thus erroneous SpO2 and HR estimation.
In this section, 3 peak-trough detection methods developed in this research are discussed and compared; Zero-crossing, Trough-thresholding, and Crossing-crossing. All peak-trough detection algorithms were developed and applied to the extracted AC and DC signals to determine the amplitudes relating to each heartbeat and the corresponding DC offset value, respectively. Figure 4.2 gives an example of the how peak-trough detection algorithm identifies amplitude
92

information form PPG. The amplitude of the rising edge of an AC beat is the difference between the corresponding peak and the trough.
Figure 4.2: An example of PPG data with identified peaks and troughs.
4.3.1 Zero-crossing method The Zero-crossing method iterates trough the RD and IR AC signals in turn, and counts instances of signals transitioning from a positive to a negative voltage. A single pulse is defined as a time period in which a signal has transitioned from a negative voltage to a positive voltage, and vice versa. For each identified pulse, the local maximum and minimum are taken to find the corresponding peak and trough, respectively. In addition, a thresholding process is used to ensure that erroneous transitions due to noise or dicrotic notch are not counted as signal transitions. Essentially, this process adds hysteresis to the Zero-crossing counter. An empirically derived
93

thresholding factor, based on several test PPG data, is used to provide optimum peak and trough detection.
Some of the research PPG data presented in this thesis, such as in Chapters 5 and 7, used this method as a part of PPG processing and analysis. However, the Zero-crossing method is not very robust. The algorithm often misplaces or ignores peaks/troughs if the PPG data is not of good quality (low SNR and/or amplitude), such as during bad perfusion. Hence, other robust peak detection algorithms were investigated to overcome the shortcomings of this method.
4.3.2 Trough-thresholding method The Trough-thresholding algorithm initially uses the troughs identified in the Zero-crossing module to create a series of linear thresholds for a given data set. A linear threshold gradient is empirically calculated between any two adjacent troughs, as originally detected. In addition, a vertical offset is calculated, based on the difference between the amplitudes of troughs and the relative DC value. This offset is then scaled until a desirable threshold height is obtained based on the AC pulse amplitude.
Using the calculated gradient and offset data, the linear threshold is divided between the determined trough positions and interpolated over the full range of the data set. The following criteria are used to search for peaks in this method:
1. Initiate search from the beginning of the array, until a rising edge crosses with the threshold line.
94

2. Iterate through the array from this point until a peak is found, identified as point which is larger than its immediate neighbours.
3. Scan ahead for a number of data points for any larger peaks. If a larger peak is found, move to this index and repeat this step. This is to prevent detection of any false peak due to noise or other artefacts.
4. Once the peak position has been confirmed, skip a number of data points and subsequently start search for crossings again. This is to avoid any false crossings being identified, specifically around the diastolic peak/ dicrotic notch area.
5. Repeat the Steps 2 – 4 to detect peaks for the whole AC waveform of the PPG.
To search for troughs a similar procedure is executed, except this time the algorithm searches for falling edge crossings and for a minimum point.
4.3.3 Crossing-crossing method The Crossing-crossing algorithm is an adaptation of the Trough-thresholding method, and utilises the identified positive crossing location information. The time period between each crossing is assessed based on an empirically derived minimum period assumption of 0.35 s. In particular, if the interval between the current crossing and the next is smaller than the minimum time specified, it is assumed to be falsely detected, such as when a false positive is generated through detection of the diastolic peak. The minimum period is evaluated an as average over the previous six crossing periods. If the minimum period criteria are not met, the crossing point is removed. Otherwise, properties such as the peak and trough are determined between the two crossings, by calculating the local maximum and minimum, respectively, over the crossing interval.
95

4.3.4 Comparison tests between the three methods A test to determine the accuracy of the 3 peak-trough detection algorithm was devised. Four different data sets, taken from 3 different Subjects, were analysed using the 3 peak-trough detection algorithms. For each data set, approximately 5 min long, a period of 50 seconds were selected at random. The reference peak and trough positions for the AC waveforms were identified visually. Corresponding peak and troughs from each algorithm were then compared to the reference positions. The specificity and sensitivity ratios are identified as:

   =   +  

(4.1)

   =   +  

(4.2)

For Equations 4.1 and 4.2, a true positive reading is a peak or trough correctly matched with the previously identified “true” peak or trough. A false positive occurs when a peak or trough is identified but doesn’t coincide with the reference points. Finally, a false negative occurs where a peak or trough is not identified but should be. Table 4.1 presents the average specificity and sensitivity ratings for the 3 algorithms over the analysed AC waveform periods.

Figure 4.3 shows an example of the comparison test when the three peak-trough detection techniques were applied for a given AC signal from one of the tested data sets. The Zero-crossing method correctly identified all the troughs, however failed to detect the highlighted peak between 60 – 61 s. The Trough-thresholding method detected all the peaks, but erroneously determined

96

extra troughs between 57 – 58 s and 59.5 – 60.5 s. In contrast, the Crossing-crossing method outperformed the other two methods by accurately identifying all the peaks and troughs. For illustration purpose, only the RD PPG signal is shown. The outcome for the IR signal, although not shown in this figure, was exactly the same.

Table 4.1: Specificity and Sensitivity ratings for assessed peak-trough detection algorithms

Methods
Zero-crossing Trough-thresholding Crossing-crossing

PEAK Specificity 0.951 0.869 0.955

Sensitivity 0.809 0.940 0.939

TROUGH Specificity 0.980 0.964 0.968

Sensitivity 0.839 0.936 0.972

Average score
0.895 0.928 0.959

Figure 4.3: Three peak-trough detection methods were applied for a given PPG signal; zero-crossing (top), troughbased thresholding (middle), crossing-crossing (bottom). Incorrect or missed peaks/troughs are highlighted with dashed blue circle.
97

Although, the Zero-crossing method rates high under the specificity criterion compared to the other 2 algorithms, it lacks sensitivity and can only perform well with a good quality PPG. This issue is most likely due to the non-adaptive nature of the thresholding used and the lack of logic to prevent or minimise false crossing identification. As a result, the algorithm tends to skip actual peaks/troughs, so when it finds them it is correct, but loses sensitivity in these cases.
The Trough-thresholding method performs poorly under the specificity criteria compared to the other 2 methods. Although the algorithm utilises an adaptive threshold, based on the troughs identified by the original algorithm, and contains logic to counter false crossings, the variation in signal quality, shape, and form is not fully taken into consideration by this algorithm. It has been found that manual tuning of the threshold and logic is needed for optimization of the algorithm, with respect to each waveform, which is time consuming and lacks robustness. The specificity ratio for this method is high for trough detection. However, the relative sensitivity of the method is low. As the function bases the threshold on peaks identified in the original algorithm, if the original algorithm fails to detect a trough there is a chance that the adaptive threshold will not intersect the waveform near the trough. This issue often occurs where one trough’s amplitude is higher than its neighbours.
Upon viewing the average specificity and sensitivity scores for each peak detection algorithm in Table 4.1 and their application in Figure 4.3, it is clear that the Crossing-crossing method performs the most accurately and consistently over the tested data sets. This method overcomes the shortcomings of the other two, and is thus, considered more versatile and robust. However, this
98

comparison test was done at a later stage of this research project, and was applied only in the processing and analysis of data presented in Chapters 6.

4.4 SpO2 assessment
4.4.1 R value estimation AC signal amplitude, |AC|, information obtained using the peak and trough detection are used for SpO2 assessment. Additionally, for each identified AC pulse, the corresponding DC value was determined by calculating the mean DC offset, DCmean, between peak and trough indices for each amplitude calculation. The ratio of the |AC| to DCmean values for each of the RD to IR signals, as illustrated in Figure 4.4, is used to calculate R value for each heartbeat, defined as (Walton et al., 2010):



=

(||⁄) (||⁄)

(4.3)

Figure 4.4: Amplitude |AC| and corresponding DCmean values determined from IR AC and DC signals, respectively, as an example.
99

R values can also be estimated by using the root mean square (RMS) of the AC signal and the DC offset signal (Oak and Aroul, 2015; Markandey, 2010). Using this method generates an array of RMS value ACRMS elements. Dividing each of these elements with the corresponding DC element will give a ratio, which is also referred to as the perfusion index. Similar to the peak-trough detection, taking the AC to DC ratio of ratios of the RD and IR waveform, the R value can be easily estimated:



=

(⁄) (⁄)

(4.4)

The advantage of using the RMS method is that it can provide an effective value of the varying AC signal, without depending on amplitude information. RMS is a measure of the magnitude of a set of numbers, by squaring every element in the AC signal and taking the square root of the average. This process overcomes some of the shortcomings in peak-trough detection algorithms, particularly if an incorrect peak is identified. However, this method has a few drawbacks. In particular, since it relies on the mean power of the signal it can provide erroneous R values, such as in the case of a PPG signal that has regions of no pulsatility. In addition, beat-to-beat (instantaneous) SpO2 or HR cannot be calculated using this method. Thus, RMS based SpO2 assessment was excluded from this research project.

4.4.2 SpO2 estimation The PO system was not calibrated against whole blood data and thus cannot directly estimate oxygen saturation. Therefore, published empirical calibration equations, such as in Chapter 2,

100

